Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Vibrio parahaemolyticus RIMD 2210633, O3:K6

>gid:500862  VPA0038  glucosamine-6-phosphate isomerase
MRLIPLTRAAQVGKWAAAHIAKRINDFKPTAERPFVLGLPTGGTPLATYK
ALIELYQAGEVSFKHVVTFNMDEYIGIPADHPESYRSFMYNNFFNHIDIQ
EENINLLNGNTDNHEAECKRYEDKIKSYGKINLFMGGVGNDGHIAFNEPA
SSLSSRTRIKTLTEDTRIANSRFFDGDINQVPKYALTIGVGTLLDAEEVM
ILVTGHNKALALEAAVEGCVNHLWTVSALQLHPKAVIVCDEPSQQELKVK
TVKYFSELEAENIKGF
>gid:500879  VPA0055  chitinase
MIRFNLCAAGVALALSGAAVAAPTAPSVDMYGSNNLQFSKIELAMETTSG
YYDMVKYHDQAKITVKFNQWSGTPGDTYNIYFDGVKVATGAITGGQTTAT
FDYGQGGLYQMEIEACDATGCSKSDPAEITIADTDGSHLKPLTMNVDPNN
KTYNTDPSVVMGTYFVEWGIYGRNYTVDNMPADNLTHILYGFIPICGPNE
SVKSVGGNSFNALQTACRGVPDYEVVIHDPWAAYQKSFPQAGHEYSTPIK
GNYAMLMALKQRNPDLKIIPSIGGWTLSDPFYDFVNKANRDTFVASVKKF
LKTWKFYDGVDIDWEFPGGGGAAADKGDPVNDGPAYVALMRELRAMLDEL
EAETGRTYELTSAIGVGYDKIEDVNYADAVQYMDYIFAMTYDFYGGWNNV
PGHQTALYCGSFMRPGQCDGSGVDENGEAYKGPAYTADNGIQLLLAQGVP
ANKLVLGTAMYGRGWEGVTPDTLTDPNDPMTGTATGKLKGSTAQGVWEDG
VIDYKGIKSFMLGANNTGINGFEYGYDAQAEAPWVWNRTTGELITFDDHR
SVLAKGSYAKSLGLAGLFSWEIDADNGDILNAMHEGMAGGVVPQPNRKPT
AAAGADQSVTGPASVVLDGSQSKDSDGTIASYAWEQVSGTAVVLAGANTA
KASFDAAEVTVEEQLTFKLTVTDNEGATASDLVVVTVKPAGVVDPVNNAP
VAQVVAPATANAGDVVVVDASASSDADNDTLTFNWTLPQGLNATVNGSKV
TFTAAEYPQDTSLSFTVSVSDGKASSSASATVVVAQHTTDPNPGTCDNAW
DASAVYTGGNQVTHAGKTWEAKWWTQGDDPSKSGEWGVWKEVGVANCN
>gid:500904  VPA0080  putative sugar-phosphate isomerase
MKIALMMENSQAAKNAMVAGELNSVAGGLGHDVFNVGMTDENDHHLTYIH
LGIMASILLNSKAVDFVVTGCGTGQGALMSCNLHPGVVCGYCLEPSDAFL
FNQINNGNAISLAFAKGFGWAGELNVRYIFEKAFTGKRGEGYPIERAAPQ
QANAAILNNVKAAVAKDVVEGLRAIDQELVKTAVGSTQFQECFFAHCQVP
EIAEYVKSLLD
>gid:500906  VPA0082  putative 2-dehydro-3-deoxygluconokinase
MNPISRVAIIGECMVELKKHDGVLQQGFGGDTLNTAVYLSRLTKQHGVET
SYVTGLGHDPFSREMLTAWREEGINTDMVYLSEDKLPGIYAIETAEDGER
SFFYWRNDAAAKYWLRERALLSLVKDLCQHQMIYLSGISLAIISDDCRQM
LIELLTMCRKEGVKIAFDNNFRPKLWPNIEQARDFYSKILSVTDMAFLTF
DDEVMLWGDKHEDEAISRTKNFGVKEIIVKRGADDCFVVTQDQQHTVAAL
KVDAVVDTTAAGDSFSAGYLAKRILGGDVAESALAGHKVAGTVIQHRGAI
IPSQAMPTI
>gid:500907  VPA0083  4-hydroxy-2-oxoglutarate aldolase/2-deydro-3-deoxyphosphogluconate aldolase
MKDLNQQLSEIKVVPVIAIKDAGKAVKLAQVLIENGLPCAEVTFRTEDAA
LAIKNMREAYPEMLIGAGTVLTSAQVDEAIDAGVDFIVSPGFNPTTVKYC
QQRNVTIVPGVNNPSLVEQAMEMGLRTLKFFPAEPSGGVAMLKALSAVYP
VKFMPTGGVSPSNVKDYLSISSVLACGGTWMVPGDLIDNEQWDELAKLVR
EVAGIIE
>gid:500922  VPA0098  putative efflux pump protein
MSHQITADKRGIATVAVMLSAIMVLIDMTVANVSLSHMMGALGATADQIT
WVLTGYSMAEAIFIPMTSFWVSRFGERKVMLVAVIGFVIASALCGQAQSL
EEMVLFRIIQGAFGASVIPLAQSTLVQIYPYEQKGKAMAIFSIGILLGPI
LGPVVGGVITDNINWRWIFYINLPFGLICTSLIYRYIHIDNKSKPNFDWW
IIGYMALGVGALQFVLDKGNEEDWLNSRMIQTAILLAVMGSVMWIYRSWK
TKSPIAPLWLLKDRNLMVSSLMIAVVSMAMFGLTTQQPMLLESLLDYPVS
TTGLLMAPRGLASAAMLILVIKLNPQFDPRIKIVFGLSCIGIGSYLMTQY
SLQIDTFWIVMPSMIQGMGLGLTFSTLSTLAYLTIPKEQSVAAASIYNLF
RTIGSSFGISIATTFQYRDSQQQWHALGEGINPYNPNLHDWAANQGLSIT
DPVALDQYQQMLQQQSQMVAFVHTFQLVGVMFVIMMPMLVFIRSRE
>gid:500926  VPA0102  putative isomerase
MFKKSTLAILIGATISLVGCGSNDKTEIRLPQAPTSEFTNVIDRTGNPTY
LRDYDSYSNLKYNALTDNGAWHGHLLPEDAAGYGAFGGIMQVTQEYAHFM
SGQTFDKLTLTDKVSGQTYDLSNAEAKVYSIPGALVQVLDLDDIHVQMVL
RFVTDRSSLVETLITNKTDRDMNLALEWDGELVKYALSTRKDQTVAQYYP
DYKRQISTIENGIKINFSEMKDNWAIRNDRDAEFRITRSLPTKTFTNETS
FSSTAEMSLPAEQTSAVYTAYSNLHNAKEVQSESLKLQDVLANPTQYMEA
SKARWDGYLANGLINKEATAEQARVAVKAMETLNGNWRSAAGDIEQATVT
PSVTARWFSGNLTWPWDSWKQAYAMAHFNPDVAMDNIRTVFQEQVQADDK
IRPQDKGYLLDVLTYTKPVSRGGAGSENWNERNTKPSLAAWSVMEVYYAL
VNQFDRPEDAQKFIDEMYPKLVAYHDWWLSNRDHNQNGVPEYGAAVDPAH
NTKEGVMYVWVETRDPNFTTIIPAEDIIEQNGNSYKVKGMASYNKILDEV
DYMTIHVGAQEAAGWESGMDNAARFGFIYNIHNMNSQAEDISNPDRNVDQ
LGRYAASAYGFDNSIKLEGEEWVYSNTSAENLAKLDLAKKDWEVRFAENR
TNNNAADGKLLGFSMLQESVDQASYMYSDNKYLAEMAKLVSDGVEGKDRA
QEFLNGAEKIKTYINQCMFDESTGFFYDIHLNVAKDGTTPAPLANGCAGL
PIVERGKGPEGWSPLFNGAATQEHADKVIAVMRDQDEFNTPDKFQGTGVP
LPTASQTNPAYGKDVYWRGRVWLDQVYFGFRAMENYGYKEEAIAMANELF
NNAEGMTGDMPIRENYNPETGAVQGASNFSWSAAHLYMMYNGFFKN
>gid:500940  VPA0116  permease
MNLILILLGVIAFIVLTTTKFKLHPFLALIIAAFLAAFAYGLPADSIAKT
IASGFGGILGYIGLVIVLGTIIGVILEKSGAAITMADTVIKVLGERFPTL
TMSIIGYIVSVPVFCDSGFVILNSLKESLAKRLKTSSVAMSVALATGLYA
THTFVPPTPGPIAAAGNLGLESNLGLVIGVGVFVAAVAALAGMLWANRFQ
HVEPDGIEAADEIQHDWQALKASYGKLPTASQAFAPIFVPILLICFGSIA
KFPSLPLGEGFVFDVLTFLGQPLTALVIGLFLSVRLLKSDNKIEEFGERI
SQGITAAAPILLITGAGGAFGAVLKATPLGEYLGTTLSALGVGIFMPFIV
AAALKSAQGSSTVALVTTSALVAPMLTQLGLDSEMGRVLTVMAIGAGAMT
VSHANDSFFWVVSQFSRMSVGLAYRAQTMATLVQGVTAMALVYILSLVLL
>gid:500941  VPA0117  conserved hypothetical protein
MKVVIAPDSFKESLTAKQVSEAIKTGLARVWQDAEFVTVPVADGGEGTVQ
SLIDATQGEQVFTTVTAPLGNDVEAFYGILGDGETAVIEMAEASGLHLVP
SDARDPKLTSSIGTGQLIKHALDRGIQRLIIGLGGSATNDGGVGMLTALG
VTFLDESGHAITPNGGGLAALASIDISGLDPRLAACEVLVACDVDNPLCG
DKGASAIFGPQKGATASDVTLLDNALRKFGELTEQATGKHVLTREGAGAA
GGMGAALLGYTPARLQPGIEIVLETVKLAQHVADADIVFTGEGRIDHQTA
HGKTPMGVAKVAKQFDLPVIALAGCVGDNYQAVYECGIDAVFACVPRAMS
LSEAMKEADVNVANLAENVARMWQIKSH
>gid:500943  VPA0119  hypothetical protein
MLIRAIPFVFVILWASGFVGARFGLQYAEPATLLSIRMAFNVLLFLVLVA
VLRRRLPTGTDFWHSCVVGALIHGFYLGGTYFAIALGMPAGLSSLLVGIQ
PILTAALLVAFVREEFKPSQWLGLALGFVGIAMVLMGKMEWQSEQHKVLA
IGLCLLALVGITLGTLYQKKHCQQVDMVGGATVQYLAALIMFLPVAMQFE
TMQVQWELEFILTVLWLVVVLSCVAILLLLYMVRNGASSSVASVFYLVPP
TTAIQAWLAFGESFDWMGISGFVLAATAVYLVVKKPDLTIKKAIKTEYT
>gid:501000  VPA0168  multidrug resistance protein D
MSASFPLAKLTFLIAILTAVGQMTQTMYVPSIGHMAGEFLVSASSLQAVM
ACYLIPYGLSQFAYGTLSDRLGRKPIIIVGLLIYILGTLVALFAHQFEWF
LAGSFIQGLGIGCGGAMSRTLTRDCFEGAELHRANSLISMCVIFSPLMAP
VLGGYLTEAFGWRSSYLFLALFGIAVVITMMTSMMETLPKEKRKFEPVAK
SYKHVLSDRRFQGFLICLVATFAGVGVFEAAAGVLLGGVLALPATTVSLL
FILPIPGYLVGAGLSSYIAQRRSERRALNVGLVSIFIGSAVVLIPGLFGV
TTALTLIGGATIYFLGAGILFPAATTGAIAPFPYHAGTAGATLGGMQNLG
AGIATLLASLFPAHNQMPLGVLMMAMSIVAMLGLLWVHRAHDHSNEMPQV
I
>gid:501012  VPA0180  phospho-beta-glucosidase B
MIEFPDNFLWGGAIAANQVEGAYNLGGKGLSTSDMLPNGILSPHQTREER
TPGIKDLAIDFYNRYPEDITLFKEMGFTCLRLSIAWSRIFPNGDELEPNE
EGLAFYDKIFDELAKHDMQPFVTLSHYEMPYALVENYGGWGDRRVIEFFE
RYAKTVLERYKDKVKLWLTFNEINMSLHAPFTGVGLPEDATEQQIYQAIH
HQLVANAKAVKLCQEIVPNGKIGNMLLGAMNYPYTCNPDDVLAAMHENNK
WLFFGDVQTRGQYPGYMKRYFRENGIEIQMQDGDLEDIASASVDFISFSY
YASGCASADPKQKEVGNIVESVPNPYLEKSQWGWLIDPKGLRILLNFLHD
RYQKPLFIVENGLGARDEFDENGEIQDDYRIAYLNDHLVQAHEAILDGVE
LMGFTSWGPIDLVANSTAEMSKRYGYIYVDRHDDGQGTLERKRKKSFYWY
QDVIRTAGGSLKR
>gid:501063  VPA0230  putative sugar phosphotransferase component II B
MKIMVVCGHGLGTSLMMEMSIKSIVKELNVDAAVDHIDLGSAKGTSCDIF
IGTKDIAEQLEALGVEQRIVALDNMVDKVAMKERLSVALQELGAL
>gid:501064  VPA0231  phosphotransferase enzyme II, A component
MLRELITSDVIRIHSDATDWKDAISKSCEALIENGAIEPSYVEAIYRSHE
ELGPYYVVGPGMAMPHARPEDGVNRLSLAITVIQNGVNFNSEENDPVKML
VTLAATDSNSHVDAISKLAELFMNEEHVEAICNAQSKEDVLAIIDKY
>gid:501074  VPA0241  hypothetical protein
MDFLAIALVVFSAVLHAGWNILGKSHSGSGVAFTMAASLSACGVLTPYLI
WYLTTLGWTSLPVEFWGMLAFSGIAQIVYLVGLIMAYKHADVGVIYPIAR
ALPVMMVGGFSVALGHALSSQQWLGFVLITFGCILVPLTHVRQVSLVAYL
NVGVFWALIAAIGTTGYSVVDKEALTLLTQQASTIFNDQYSAIFYLGAQF
WAMGLPVLLWCLITRNDQELQAAWRIRKSASMAGIMMASTYGLVLFAMTM
TDNVSLVVALRQISIVFGLLMGIWLLAEKWYLTRGIGVAFILAGIVLSLE
GA
>gid:501130  VPA0297  PTS system, fructose-specific IIBC component
MSTITAQATNNSDFKKLLSTMKGHLLFGTSHMLPFIVAGGVLLALAVMAS
GKGAVPADGLLADISNIGIKGLVLFPIILGGFIGYSIADKPALAPAMISS
GIMADMGGGFLGCIVAGFIAGGVVFQLKKIPLSANMTALGAYFIYPLVGT
LISAGIVLWGIGEPIKIFMASMNEFLASMAGASKVVLGTILGGMTAFDMG
GPINKVATLFAQTQVDTQPWLMGGVGIAICTPPLGMALATFLFKKKFTKQ
EQEAGKAAAIMGSIGISEGAIPFAANDPVRVLPSIVAGGIVGCVFGFLTD
VLLHAPWGGLITAPVSSNIPMYVVGIALGSLTTAVIVGFWKPVADEEAED
EIVEAAPTQAQAAPAAGEGEYDIVAVTCCPSGVAHTFMAAKALEKAGAAA
GLKIKVETQGQNGIQNRITDLDVANAKLVILAHDIQVKDAHRFAKANVVE
CSTKEAMRNAATLVKA
>gid:501131  VPA0298  PTS system, fructose-specific IIA component
MITELTNVNLIKGNLQANNKKEVFEELAKMLFENNRISSKEAFLTDIEAR
ETLSVTSMDGIAYPHAKSKAVTEPAIAVGVKREGIEYGDEEGVKPTVFFM
IASPDNGADHHIYVLQELFGKFSEEFIEDIHNAKDENQILNILINS
>gid:501136  VPA0303  putative regulatory protein
MNPRQNEILQLVNDRKRVQVTELSDIIGVSGVTIRQDLNFLEQQGYLKRV
HGAATALQSDDIDTRLEVRFDIKQTLANKAADLVAPNETVLIEGGSANAL
LARTLAERGDVTIITPSAYIAHLIRNTSANIILLGGVYQHQGESLVGPLT
KLCIENIHFSTAFLGIDGFHQDTGFTSRDMMRADIAEAILAKKRRNIVLT
DSSKFGQIYPSSIGKTNEISVLLTDKAAPKSDLEQLKKLGVEVVLG
>gid:501147  VPA0314  hypothetical protein
MKVTSVGAAMLLLIVGNLIAVLSDSLIKSVANEVPMFQFVFFRQISAVMF
LLPVCLLAKQTNFMEGFKWHAVRAHVWLLGAVFMVMAISSLPLATANAIF
YAAPLIMLPLAAIFFGEQLSKQSVAAAVMGFAGVLVIIRPDQIDWAAISA
FVVALTLAINNLLIRKLPKNQSVMQTLLMTNLAGIPVALLLVLIEDQPWQ
WGAFPVAAGSSLFIMIYAATCVLAYRSIDSNKIASAEYSGLIGAVVVGFI
WFGEIPDIFMAIGTVMIVVPLIWLSKRERRKQKEHAQLQAQKEHEQQQAH
VA
>gid:501166  VPA0333  conserved hypothetical protein
MKNKTQPYLAGRFFDSISSGLFMMALPWVMLSEPKMGTFVALVSLSCTAI
SFLATPFFSTLVDRHSRKALLVLNQWIQSGMALVVFIAYWLGFESHWLLA
FAQLVYWVSSNFAWTTNNAFTQENYQHHEYAKISGQQEIVMQSTTLGAGA
LGIVLLEMWGMKEFALFAASASALAAMFYILTPYTQQLRASKSVAFIAQL
KESKQIFRLEPRFYGFILLSCLSYPALTYLSKLVPIWFSEQSISGDWFAG
FNISFGLGSLLTGFIVTKVLSRASHSHIMFASMVMVSLAFIGMSFAISPL
TILLFTALFGVFNALNRIARVNWMHHTVAVHQRGRVDGGISMFATTIQSL
SYVLIAMLSHYELTQYGFAIAAVVMVLAVVLMGLLSRDVEPFNDLPLHAA
AK
>gid:501190  VPA0357  putative beta-mannosidase precursor
MAQIELNGTWQLTSPQRPDIDIPMNLPGDNVSALLQAELIPNPYFADNEA
KVRWIEACDWHIERQFEVGDSTLCASHIWMTLTRVDTLAQFFINGERVLT
SSNMFAQQRVDIKPYLKQGTNTIRVEFARVDLEGIARAKKLPFPIPSAMG
NNQIPHMNLIRKTQCHSGWDWGICLMVSGIYDPIQIDVVTDIWLKNVSTE
QQWQADGSVILDVLLEVQTDNQSHHVVVEFDGEVQFIQTEGSGHYHCQFH
VQKPQLWWPAGYGDAHLYTISVGCGEQTLSRKIGLRQLSLNSQADEHGSA
MEFIVNGTPINAKGANWIPVDAMPGRECERRYRDLLQSAVDANMNMIRVW
GGGQYESETFYKLCDELGLLVWQDMMFACSLYPSNDEFLKDVEEELRFQI
PRLKAHPSIALWCGDNEVIGAIGWYDESKHNKVKYTVNYDRLNRMIEQVI
TQQDDSRRFWPSSPCNGELDFGDAWHDDSKGDMHFWDVWHSGKSFSAYLN
INPRFCSEFGFQSWQSFAEVKQFVPERDWNITSPTFEQHQKNPRGNSIIT
EMFTRYFCFPSGFEQMLYLSQVQQAMAIKTACDHWRAISPICRGMLYWQL
NDNWPVSSWSSLEYSGRWKQLHYHAKRFFAPQYLVFSEHTGKLSLHLLND
AKEPASVNAQLKWVDWQGEEKQCWSLEQTVIADSNTILWQLDESFEKDEL
TSGFFYVEAQIGEDRISNTWFCTHELKTLPMAKANIDVSIEDSQITLVAD
KPAFFVHVECDTQGRFSDSSLTLLANQPVTIEFLGDDLAAMSASLRVYHL
MQ
>gid:501205  VPA0372  phosphoenolpyruvate synthase
MFLEKDMQKNTLWFNGLSMDDVDKVGGKNASLGEMVSNLANVGVSVPNGF
ATTSYAFNQFLDHEGLDERIHQLLDELDVDDVEALRKTGATIRQWVLQAP
FPADLEQEIRNNYEELIEGNTELSVAVRSSATAEDLPDASFAGQQETFLN
VKGIDAVLEATKHVYASLFNDRAISYRVHQGFDHRGISLSAGIQRMVRSD
KASSGVMFTLDTESGFDQVVFITSSWGLGEMVVQGAVNPDEFYVHKPMLE
AGEHPIVKKTFGSKLIKMIYSNNQEIGKQVDIIDTSEEERNTFSLNEEEI
KELAKQAMIIEKHYQRPMDIEWAKDGIDGKLYIVQARPETVCSQTEQNVI
ERYELNNKADVLVEGRAIGQRIGKGPVRLVDSLDQMSLVQEGDVLVTDMT
DPDWEPVMKKASAIVTNRGGRTCHAAIIARELGIPAIVGCGDATSKLTDG
ATVTVSCSEGETGYVYQGDLDFEVKRSSVDELPLLPTKVMMNVGNPDRAF
DFAQIPNEGVGLARLEFIINKMIGIHPKALLNFDAQSDELKAEIKQRIRG
YKDPIDFYVSKLTEGIATIASAFWPKRVIVRMSDFKSNEYSNLVGGKAYE
PHEENPMLGFRGASRYISPVFEDCFELETQAIKRVRNEMGLKNVEIMIPF
VRTPSEAASVIDLLAKFDLRRGDQGLKVIMMCELPSNAVLADEFLKYFDG
FSIGSNDMTQLTLGLDRDSGDVAHLFDERNAAVKIMLKMAIDAATKAGKY
VGICGQGPSDHEDLAEWLMEQGISSVSLNPDTVIDTWLQLGKVSK
>gid:501222  VPA0389  hypothetical protein
MKPSFIALAVASCIGLAGCGSDSSDAPVPVDKPIISADLYLRGLNGDWGT
AEHAKLNYLGNNEYETVLRVARGSNQFKIADPGWQIQYTYFEEPAAFDKA
QEYLPKPDTNEACMNGDCNSEITFEDKGYYKFSVSFADESRATMTVTKAT
QEEAEKYYSDAILDPAMVHEGHQNKEVKLFANYDDSSDTVIFSVKDPKAE
LREFGISTTTELRDALDQGLVINEQTGPRVVSGDVAFDALFALTMKELDQ
LAVSEIKDGNYNYNNPIKAEVFETGAKWHYVWTRDLAYAADLSLALMNPT
RVQNGLNFKLSAFRDTTDQQYDGEQIVQDTGTGGSWPISTDRTTWTLGAE
RLLSALDGEEYNQFAERAYKAISNTLEADRLAAFDAKSGLYTGEQSFLDW
REQTYSTWTPNDVNAIGSSKALSTNVVHYRAIQLAAKLAEKYDSTNAVKY
TEWAAQLKTAINEQFWNAERGMYVSYLFDNGKDIAVDKYDMLGEALAIIS
GVASDAQAKQIMTNYPHSEFGVPVYFPQQPDVPVYHNRAIWPFVTAYSLR
AAHQTQNVAAANNAIQSLVRGTATNLSNMENLEWLSGKSFIIHSDHGEDP
SLDGPVINSQRQLWSVGGYLNMVVETLFGIHTETGKLEVKPFITSWVRNK
LLAQSEQITLENFAFKGKNYSVTIDLPEVSKDETGYYPVENVTMDEEGHF
HVTLGAFVNVDSSITLVSGVKPYVSEDSRVYSPQEPTLVVKSVDNSVSID
VTSKYNVNLYRNGELIQKNVIAQSYSDTPTGFACYLAESINDKGFRSNPS
QPVCVGEEIRIKLDGEYQPLKDNVSVVTVSKDSGIVKGAESFTAPVTGTY
QFDAWYNNNLGQLNTGITNTVKLLEVLDDAGKVVGQGYLQMGHIGENQGM
RYSTPIEVALEQGKTYQFALKDHFNMSYLTSNETYIYAGGIEGEKNEAQI
ADIRITPLM
>gid:501236  VPA0403  putative membrane protein
MVYLLPFFTVMIWGGNSIVNKMAASTIEPSAMSFYRWFVAMVLLTPFCLP
AVIKQRHVIRPYLTKLAFLALLGMVLNQSLGYYAGLTTTASNMALITSLV
PLISVFLSVPLLGKSVSMLSIVGGVISLGGLAFMLGHGDVTYFLHQDMTQ
GDSLMLLAALVYAAYCVLLKRWKMPFNSLTLVYMQGFFSVIMLTPLWLSS
EQLLPSQEALPLIAYAGIAASIFAPLMWVKAIDLIGADSSAMFMNLMPVV
SVALASTLLGEEIHVYHIIGGLMVISGVILSQIKVRKKQDLVVSESLTTT
TR
>gid:501272  VPA0439  hypothetical protein
MIVFKGLDMTYVNNSKLKAKLACALEYSDLSRRQMAVFDNACRLSGVGRG
LSRSRIFRLLQTLDTLTYDSLERRLNVSLKALSRESYSKRTIALYLSVCR
KVASQLAQMYGIPRHETTIPESEFQYRPSVSDKRVFTVAERMLPKGAKYL
IVSMSTLEEALRLKPRTIRESLKRLDHHGYIVCLGGDEGANYSITFKRSI
HATSALSLQAA
>gid:501280  VPA0447  hypothetical protein
MSVVKECIAMSRFYVDYWSREWVDENDFPEAELVSFKEDYANRDLGVAFS
GGGTRSAACTVGQLKALDELGLLPRVKYISAVSGGGWAATPFTYTKNTEQ
YFGEIRDPENITCSNSKSVHPKSMQSAITNSPLISNLITGGLKLKGDESF
AYSLGEVFLKPYGLHDSSRYFTFNEETEALTRQGFPPNTKTDFYLVRKGA
PYLILGATLLNEDGLASDKKYHVEYTPFYSGVRVGHIDKDLWSSNDYFGG
GYVTSCGYDCIGPYNKRTLEGREQLLVKQAPVLSFDITNEKAFSLNDIIA
STGAAPQEITNNIRLGALGFPEFNHIPLNTLEGDNSVSEEYPHSDGGHLE
NLGIMPLLARKMTKIVVFVNTKKPFTPNKKKPLDSGFNKSVKALFVPIDN
LFKKGDFATNVVFDNGEEELTKLIGQFSQLVKKESSSDEYIAKTALFAKT
KLVTTSNEHYGINAGHEVEITWVYNCRSSAWEKKLKDKDLGKLIANKKRL
IGDQKGLEDFPHYGTFFENFRGVVELTKVQTNLLTNLSYWVAKKALNGV
>gid:501294  VPA0461  alpha-amylase
MSGLQETQSAGANVILHAFDWKYADIAQRANEIHELGYGSVLVSPPMKSA
HDERWWQRYQPQDYRVIDNALGDTQDFIYMVRELERVGVLVYADVVFNHM
ANEAHLRRDLQYPRQDVLDQYRQNEHKYQSLKLFGDLSKPLFSEEDFVEA
FGIKDWKDKWQVQNGRITGGPTDPGLPTLRVCEHVVEQQRAYLKALKAIG
VKGFRIDAAKHMTLEHLKRVWTDDITQDVHIFGEIITDGGATEEEYQLFL
EPYLQETRLGAYDFPLFSTIFKAFSKKGSFKSLIDPYCFGQALSNGRAIT
FVVTHDIPNNDVFLDLIMDEEDEWIAYAYILGRDGGVPLVYTDLDTSGIK
NKNGKPRWKDAWNDPRMAKMIAFHNVTHGESMTVLEGNDDMLVLKRGEKG
IVVLNKSTRAQSLSLKTECDWFDLMSDQSVKAGIELKVPAKSFMLLVQK
>gid:501325  VPA0492  conserved hypothetical protein
MTTTGHVHFYIGTYTNPPSTSTSTGIARLSLNTETGELTRLDDVVVQRNP
SYLTTTEHGLYTFSEMDRNEGTELAFFRGSESVSLPINGDYPCHLDIKEP
LLAVANYGSGNVSVFQLDRDGKPLGLLADLYVDGCGPNLERQTSPHAHQV
TFLKHSHQLVVVDLGSDSVLIYDYDAQPPDFSLSQVIHLPAGSGPRHVVF
NQQESTAYVVCELSETLIVLVKHQDKWLISNQTELLEGEENQQAAAAIRL
SQDETFLYVSCRAQNKISMFDVSGDTPKRRAAIHCEGVFPRDFVLSHDQK
WLLVANQHSNNVVSFRRNPQTGEITPTGYDCEIGSPVCIVEQPL
>gid:501333  VPA0500  putative PTS system, mannitol-specific enzyme II component
MLYELIDHELVDVINDRAYQWQDAVKKTTQYLENKGYVSQHYADAIIRST
EENGPYYVLCPGLAMPHARPETGVLKTGLGIHIFPSPVDFGSDLGPANIL
ITLAAKDSDTHIEVIQALSEMFVDEENIAKLAQASSKEQVLDIIKAY
>gid:501334  VPA0501  mannitol-specific PTS system enzyme II component
MKANMRANVQAFGGHLTAMVLPNIGAFIAWGFITALFIPTGWMPNEAFGE
LVGPMITYLLPLLIGYTGGQIVGEKRGAVAGAIGTMGVIVGADIPMFVGA
MIMGPLSAWVVVQVDKRIQHRIPSGFEMVVNNFSLGIVGMLLCLFAYEIV
GPSVTAANLFVKSGIEALVATGFLPLLAIINEPAKVLFLNNAIDQGIYYP
LGLQAAAETGKSIFFMVASNPGPGLGMLLAYAKFGQGLSKRSAPSAIIIH
FFGGIHELYFPYVLMKPIMIVAMIAGAATGIATFNLFDAGLVAGPSPGSI
FSYLALTPKGSFIATIAGVTSATIVSFLVASAILKVSKSEEKESEFEKSV
SDMKEMKAEGAVKPVAAAATTQEPSKPISFVAFACDAGMGSSAMGASTFK
RKLVQAGIDIEVKNFAIEKVPSEADIVVTHESLESRAVNATGLPVVTIKN
FLNDPALDELMDKIKQQTVATEQPA
>gid:501353  VPA0520  multidrug resistance protein D
MRKTPLLLAMMIIATGQVGVSIYLPSLPLIGHDLNLPQPSIQSLVTLFLV
GFGVSQLFYGPLSDAIGRRPVFILGQSICLIGTVICIVFGDNISALEAGR
LLQGLGAGSASVLGRSVLRDSYDGMQLTKALSYISVTASVMPIVAPLFGG
WIAYHFSWQAVFVFVLLYLLAIFILGYLVLPETLPYPKRKFEVRQVMVNY
FYLLTNKQVIGSASYNWLSYLSGLVTLSLYPFLMQQELGLTAADYGSLMI
IPSAGLLMGSLVLNLINNRYKAQQILLMSFAIVALSGCLLLVTPFTVASL
LVAFTCLSFAQGMSFPVSISLLLSPHKQQAGAVSALSGSIQMCLAGLFGG
YLVEKWVTDQHQLGIFYLFIALISCIVLVVSQYRRAPRQTAQPEASS
>gid:501358  VPA0525  putative transporter, DME family
MNHHPVQGASWMLTAGLAFAIVNSFAQIASIHFGVSSTTFALFQYAIALF
VILPYLRTLGIRRSLRTQHFGWHAFRIFLSVIGIQLWLWALAYPVPIWQG
IALLMTSPLFATVGSGLILKEKVGTARWLATLTGFIGAMIILEPWSDSFT
WATLLPVGAAFFWAAYSLMVKKMSVNDPPSTMVVYLLLLITPFNIVLAIP
SFTMPSDWTIWLILLFAGALTALAQWAIVKAYAVADASFVQPFDHAKLPL
NVLAGWMVFGWVPPGRLWLGAAIIVASIAFITHWEAKKTKLVERKI
>gid:501368  VPA0535  putative phosphomannomutase
MTALITQWLARDPDPKTREELQHLVDTNNEQELSDRFGSRLAFGTAGLRG
KVGAGPNRMNRLVIQETATGLGHYLLEQVQDAASRGVVIGYDGRPDSKQF
AHDTASVLTALGIKVYLTYQVAATPIVAFGVRTMNAAAAVVVTASHNPPE
YNGFKVYWENGAQIIPPHDSGIAAKIDEATTKPLPLMSLDDAKQQGLLVW
LEDDYYQTYRKTMNENALLTPDSNTDISIAYTAMHGVGADMAETLLADAG
FKKVASVAEQREPDGTFPTVNFPNPEEAGAMDMVMALGKSVDADIACAND
PDADRFAVAVKRPDGEYQMLTGDQVGSLFGDYLLEQQPNSLVGNTIVSSR
LLSSIAKAHGAEYYQTLTGFKWLTNVAMSQETEQHPFLFAYEEALGYTVG
NKVWDKDGLSAIVAFSQLTGKLKAQGKTLWDKLEALYRQHGFYFNAQRSI
ALDPNSPPIGDKLRANPPSEIAGKKVSVTEDLKTSVRTFEDGSEETIDLP
ASDVLIYHLEDKSRVIVRPSGTEPKLKCYYEVISDFPADMSYEQAQQAAE
AKMNALIDAHQKSL
>gid:501398  VPA0565  putative glucose dehydrogenase-B
MLAFKASTHFNMEGPMRIVTIALLACLSFSLHAAQYHADEVANGFQVPWG
IEFIDSQRVVVNEKNGTISLLNVMTGQRQKIHTVQNVNTSGQAGLLDVAL
APNTDKKNPQLYFTYSKRTQKGNTVALATATLNGEQLTGWKDLFIADAIT
DTGRHFGSRIAFIDGKIYFTIGDRGERDNGQNTQTHAGSILRLNLDGTVP
TDNPFTSSKAKPEIWSFGHRNPQGLFYDKETDQLWSIEHGPRGGDEINLI
KKGANYGWARVSQGKEYWGPLDVGEAKSLPGMEDPKLVYIPSIAPSNMVL
YRGDKYSELDGKILVGALKLTHINVVGINDGKLTESQRLLEKLGERIRDI
TISPDGYIYFSTDSGKIFRLTEQ
>gid:501402  VPA0569  putative permease
MKSVQFRFTLYGCIAILSWSCLLGIARLVTESLGPVGGAAMLYSLSSIFL
LIVVGIPKLSYFSPKYLIVGGAMFVCYEIFLALALGYSNSRAQAIEVSIV
NYLWPALTVLFAVLGSNKKPNWLLYPAVTLAFIGVAWTVSGDNGLSPTQI
ISNVSSNPLVYFMAFTGAVIWAVYCNLTQRQQSKHNAITLFFIATAVSLW
VKYAFADEPTMTFSWSALGYLFASAALMAGGYGLWNIAIVGGNMVFLATL
SYFTPIFSALFSSLILGVTLSNSFWQGVVMVTVGSLLCWLVTKEKREAAG
>gid:501447  VPA0613  putative permease
MFNSERKATVILVATTMIAALGWIFSKETIQGLPPFGFIGLRFTIASLCL
LPLCFRPLKAARLKDVLAASGVGLLLGGAVMTWIYAISISDTLGEGAFIM
SLSMLFVPIVAWVMFQQRPQRIFWISLPIAVIGLACLSLAGGWKQSASQL
WFLGAALILALHFNVNSKYSQKLPVLLLTCVQLFSAGCLGLLVSFLMESR
PEQVDSSIWWWFALSTLLATSLRYVMQTMGQKFVQAGNAALIMILEPVWT
VVLSILWYGEVLTANKLVGCLLILFSLVIYRTGGRFRFPKRA
>gid:501503  VPA0669  hypothetical protein
MIMPVSGIHSGQQIMQLSHKMADKAAHEIQQTFAKGGEDLSFNKVELAKN
VAFAANPSLAAHATVIEPLIEVTQAASYNRIGASVVEKNNEVIGSLLDIH
V
>gid:501507  VPA0673  methylglyoxal synthase
MQKTTRTMPAHKHVALVAHDNCKPELLRWVKENKEKLQRHFLYATGTTGH
MLSKETGLAIKSMISGPMGGDQQLGALISEGKIDVLVFFWDPLNAVPHDP
DVKALLRIASVWNIPVATNRATAKFLFDSPLLEQEVDIEVPDYEAYLAER
M
>gid:501508  VPA0674  periplasmic protein TorT
MVINQRSIRTIFKHSVLAASLCASLPSVAAEKICAIYPHLKDSYWLSVNY
GMVSEAEKQGVNLRVLEAGGYPNKSRQEQQLALCTQWGANAIILGTVDPH
AYEHNLKSWVGNTPVFATVNQLDLDEEQSTLLKGEVGVDWYWMGYEAGKY
LAERHPKGSGKTNIALLLGPRTRGGTKPVTTGFYEAIKNSDIHIVDSFWA
DNDKELQRNLVQRVIDMGNIDYIVGSAVAIEAAISELRSADKTHDIGLVS
VYLSHGVYRGLLRNKVLFAPTDKMVQQGRLSVMQAAHYLRHQPYEKQASP
IIKPLTPKTLHDDTIEESLSPSEYRPTFSIKAVD
>gid:501535  VPA0701  putative oxalate/formate antiporter
MSKIDKAMRILLAGFCINLCLGILYAWSVFNKALVTESGWSAAEASAPYA
TATITFSICLLVAGILQDRMGPRMILILGTVLTGLGMIASGFVDSPLMLN
ITFGVITGAGIGFGYACLSPSAMKWFHASKKGMVNGIIAAGFGLAAIYLA
PVTSALIDSMGIQTSFMVLGVGILAIAVPLAATINNPPADYTPAEPKVKE
GQAPKAVKKSDDLTWKAMLKTPQFYSLWIMYAFAASVGLMIIGNITTIAS
VQANLPNAVYLASILAVFNSGGRVAAGMLADKIGGVRTLLLAFVLQGVNM
VLFATFDSEFTLIIGTAIAAVGYGTLLAVFPTLTAEFYGLKNYGTNYGVL
YTAWGIGGAIGAAVVGFSMTNGDGYTLAYTISSAMMAVCIVLAFITKPLS
EAKVAQLKNA
>gid:501591  VPA0757  hypothetical protein
MVPIGVRFMVLSAFGFALMSATVKHVSLHGIPVFEIVAARALVSLVISYL
DVKRKRISVWGNNKPLLLARGAVGTFALMCVYYSVTTLPLAEATIFQYIH
PVFTALLAVIFLKERIQPTTFICIALCLLGVYVMVRPETGVESAQTLPMF
SVMIAILGAFGSSIAYVIVRKLSQTEDSSVIIFYFPLVALPTSILFMGDN
FVMPDLYLTCMLVLVGVFTQIGQLGLTKAMQTQQAGKASAYSYVQIVFSV
LLGIVFFGELPSLWTYIGGALIVAGALINVFGHHLRLPFIKRSA
>gid:501645  VPA0811  PTS system, fructose-specific IIBC component
MNIAIITACPSGVANSILAAGLLEQAVAKLGWNAKIECQSSVIAPTPLTD
ADIEQADAIVIAANTTVDTSRFVGKKVYQAEISAVAKDATAFLTTAVESA
ATLEQATTVEAPVESASATKKIVAITACPTGVAHTFMAAEALEEEGKRRG
HQIKVETRGSVGAKNQLTDQEIADADLVIIAADIEVPLDRFNGKKMYRTK
TGPALKKTAEEMDKAFEQATIYQHSGAASSASATDEKKGAYKHLMTGVSH
MLPVVVAGGLIIALSFVFGIEAFKEEGTLAAALMTIGGGSAFALMIPVLA
GYIAFSIADRPGLAPGLVGGMLASSTGAGFLGGIAAGFIAGYAAKLLADK
VKLPQSMEALKPILIIPFVATLFTGLVMIYIVGGPVSGIMNGLTDFLNNM
GSDSAVLLGIILGAMMCFDLGGPVNKAAYAFGVGLLASQTYAPMAAIMAA
GMVPALGMGLATFLAKNKFEPNEREAGKASFVLGLCFISEGAIPFAAKDP
MRVIPSCMAGGALTGALSMLFGAKLMAPHGGLFVLLIPNAISPVLMYLVA
IAAGTAVTGFTYAFLKNKADAKQEVAA
>gid:501646  VPA0812  1-phosphofructokinase
MTALKTNKVVTITLNPALDLTGSLDALKVGSVSLVEQSSLHAAGKGVNVA
KVLSDLGADVTVTGFLGKDNPELFHQLFTEIGVKNEFVEVEGATRINVKL
VEADGQVSDINFPGVQVTAEEIARFEETLFRLADTHDYFVLAGSLPGGIT
AEQCAAWIEKLHQQGKKVLFDSSKAALRAGIDAHPWLIKPNDEELSDFVG
EHLETPEQCQVAAQTLSNKGIENIVVSMGADGVMWLNQSEWLRAQPPRMN
VVSTVGAGDTLVAGLCWGHMQVMPKHDLLRFATALSALAVSQVGVGLTSQ
EELENIKLQTQVSELYPNTNLDKN
>gid:501647  VPA0813  PTS system, fructose-specific IIA/FPR component
MLKLNKNDITLSQSAADKFAAIKNIAQSLTDKGLVEQGYVEGMLNRENQN
STFLGNGIAIPHGTTDTRSMVKTTGVAVHHFPKGVDWGDGNKVFVAIGIA
AKSDEHLGILKQLTKVLGADGVEERLRDAKSEEDIIALLHGDVQLEADFD
ASLIQLLFPASDMVQMSAVAGGLLKNTGCAGAEFVADLVTKAPTHLGNGL
WLVGSDKHVSRTGVSFVSTANDCEYEGQKVRALVAFAACNNAHQSILNNL
SKIVFNNEQNKLLDASAEQILALFKGEEVAAPAEDGNVAVFKIKNAHGLH
ARPGAMLVAEAKKFESNIRVANLDGDGKAVNAKSLMKVIALGVKHGHQLQ
FSAEGPDAAQALESIGNAIASGLGEG
>gid:501657  VPA0823  pyruvate kinase II
MCKTKIVATLGPASESRETLTKLIRAGANVVRLNFSHGTAQEHIARANLV
REIAAELDTYVGVLVDLQGPKIRISCFENGAVLLNQGDVFTLSGTLDAQS
GTQEMVGLDYPELIQDVNEGDILLLDDGRIQLKVSQLHRDEQWIKTTVLN
SGKLSNRKGINLLGGGLSAPALTAKDIQDIDTAAKLRADFLAISFPRNAQ
DIEYARSLAQKAGCHAKIVAKVERAEVVETKEAMDDVIKASDIIMVARGD
LGVEIGDARLPMVQKSLINRSKHWGKPVITATQMLESMIENPLPTRAEVL
DVANAIIDGTDAVMLSAESAAGKYPIEAVEAMVRIAQGAEHELECNHDCW
DTLQHLCSNPGKSFALSSMISASRVHQDLGVAILTQHGETPLLMSRCQSK
TKIWALSDNPALLAQMTILRGVEPLYFKAAESHVDLAPQLVECLRQKANE
AHISSILMTQLDSIEGMGEINACRLLSLNVSSHMKPAEEIAA
>gid:501658  VPA0824  putative regulatory protein UhpC
MFNFFKTRPDLPLSDGSKEEMQARFKRYQWHVFLGLVFGYAVFYVVRMSL
GVVKKPMLDAGIVTIEELGIMGSAFFFTYAFGKFSNGFLSDYANIGRFMS
FSLLLSGITAVFMGLNTTAFFFVLLWGLNGWFQSVGSAPSCVSLFQWFSP
KQRGSRYSIWGGSRNIGEGITWILTASLVSYFGWRAGFIGAGIAAIAAAI
CMFFILKDRPQTYGLPDSATAFDEEPEIKKKNDPQATRRAQMFILKQPTV
WLIAAACAAMYISRYAMSSWAVLYLQEAKGYSLIDAGFAMSTYPIAGLAG
AILSGIISDKVFNSNRHIPTLLYGLANIGGMCLMFFGPDNRIVDAVALGM
IGFAIGGLVVFLAGLTACDLMPKNAVGAVKGFIGLFSYIAASGQELASAS
LIKITEVDGVTKYDFAQAQYFWLAAGVISLLLALTVWNAKKVVDIDPVEE
KELEARPSH
>gid:501666  VPA0832  chitodextrinase
MHLKNGKAVKSVFTLSTLTASCLLAFNSYAAVDCAPLEVWDSSKVYNGGD
QVQHEGNAYKARYWTQNNNPAQAGQWGEWESLGACDGTGPVDPPQNEIPT
VTLTAPSASASITAGEVVNLAADAADTDGTISKVEFFVDGALVGQSTSAP
FIASWTATEGVHEFSTKSYDDAGAVSTASSVTLTIASVQPGNEAPTVDVA
LSATSIELGGTVTLTANAADADGSIAKVDFYVAGALAGTATAAPYTLDVT
PSKAGALAVYAKATDNAGASTDSAIATLTVNGGAVASNCRPDGLYQTTGV
DVPYCSIYDEEGREKMGADHPRRVIGYFTSWRAGDDPQSTYLVKDIPWEQ
LTHINYAFVSIGSDGKVNVGDVNDPNNAATGKTWPGVEVDPTLGFKGHFG
ALATYKQKHDVKTLISIGGWAETGGHFDANGDRVADGGFYTMTTNADGSI
NHAGIEKFAASAVEMMRKYKFDGLDIDYEYPTSMAGAGNPYDKDFMEPRR
QYLWASYQELMKVLREKLDAASAQDGTHYMLTIAAPSSGYLLRGMETFDV
TKYLDYVNIMSYDLHGAWNDHVGHNAALFDTGKDSELAQWNVYGTAAYGG
IGYLNTDWAYHYFRGSMPAGRINIGVPYYTRGWQGVTGGDNGLWGRAALP
NQAECQPGTGEGEKNNCGNGAIGIDNMWHDLDPQGREMGAGSNPMWHAKN
LEKGIWGSYAQAYGLDPVNDPSDKLVGTYTRNYDSVAVAPWLWNAEKGVF
LSTEDKASIEVKADYVIDKEIGGIMFWELAGDYNCYVLDANGNRTAIDAT
EQACAAGNGEYHMGNTMTKAIYDKFKSATPYGNKVATGPTPTEAVDITVS
VGGFKVGDQNYPINPKITFTNNTGQAIPGGTEFQFDIPVSAPDNAKDQSG
GGLKVIASGHTRANNIGGLDGVMHRVSFSLPAWKDLPAGGTYELDMVYYL
PISGPANYSVISGGKEFAFKFEQPDLPIGDLNAGTGGGGTTEPGSCDTAG
LVTYPNLPQTDWAGNPSHANQGDKVIHNGVVYQANWWTASEPGSDGSWAT
VCNI
>gid:501667  VPA0833  glucose-1-phosphate adenylyltransferase
MQDALAVILAGGMGSRLSPLTDDRAKPAVPFGGKYRIIDFTLTNCLNSGL
RKILVLTQYKSHSLQKHLRDGWSIFNPELGEYITAVPPQMRKGGAWYEGT
ADAIYHNLWLLSRNDAKYVVVLSGDHIYRMDYAAMLEEHKEKGAKLTVAC
MDVPVKDASAFGVMGIAENGLVKSFVEKPENPPTLPDDNAKSLASMGIYI
FDMDVLKEALTEDAKLETSSHDFGNDIIPKLIDTESVYAYKFCGSKGRVD
KDCYWRDVGTIDSFYEANMDLLEPVPPMNLYQSNWAIRTYEPQFPPARTV
SSATGNEGIFINSIIATGVINSGGSVQHSIISSNVRIQDSATVVDSIIFD
DVEVGEGSQLVNCIVDKHVRIPPNTQIGINKVEDAKRFKISEKGIVVIPE
SYQF
>gid:501669  VPA0835  inosine-guanosine kinase
MKFPGQRKSKHYFPTHARDPLVNQIRQAPKLYRPTIVGVGQTIVDIEARV
DDAFLEKYNLSKGHSLVLEESKADALYEELVEQGLITHQYPGDTIGNTLH
NYSVLADSKSVLLGVMSKNIQVGSFAYRYLCRTSSRMNLNHLQTVDGPIG
RCYTLISQDGERTFAINEGHMNQLLPESIPEEVFEKASALVVSSYLMRGK
EEDPMPKAVQRAIDFAKKHDVPVVLTLGTKYVIEGNAEWWQEYIRENVSV
VAMNEEEGAALTGEHDPLAAADKALEWVDLVLCTAGPNGLYMAGYTDEKV
KRETTHDILESSIEEFNKFEFSRAMRKEDCVNPMKVYSHIGPYLGGPLEI
KNTNGAGDAALSALLHDMAANSFHQKEVPTSEKHEVRCLTYSSLSQICKY
ANRVSYEVLTQHSPRLSRALPEREDSLEETYWDR
>gid:501739  VPA0904  hypothetical protein
MSKSINAFVESNMVDSVEQLEVSDAVTIDVELPTVEPVPEIVASTDMPSI
AVAEPVEAPSVETEPPTDPEPVATPIKKPPFPVKKVLAGIAFVALLIWAI
RQLMPTKQPTEQGEPINAG
>gid:501740  VPA0905  hypothetical protein
MEMLSLKECQQAMAALDAADKLNASVENELSQFKNMDTNAIIKRASKMLM
TGNLSLEAFGLNPTLFQQIEQLTKLNNKVRAKYRGCVQDNIQQLESVEAT
ADE
>gid:501799  VPA0963  MFS family, hexose phosphate transport protein
MLKFLEQVRKPTLDLPVEVRRKMWFKPFIQSYLVVFIGYLTMYLIRKNFN
VAQNDMISTYGLSMTDLGLIGLGFSITYGIGKTVVSYYADGKNTKQFLPF
MLILSGLAMLGFSFSMGGGSASLFLMVAFYALSGFFQSTGGPSSYSTITK
WTPRNKRGSYLGLWNMSHNVGGAGAAGVALFGANYLFDGHVIGMFVFPSI
IAIIVGFIGMRFGSDSPEAYGLGKVEELFDEAVSEEDTAAEENQMTKKEI
FVEYVLKNKVIWLLCFANIFLYIVRIGIDQWSTVYAYQELGLSKETAISG
FTLFEVGALVGTLMWGYLSDLANGRRALVACVSLGLIIVSLEFYQHATNE
FMYLSSLFVLGFLVFGPQLLIGVAAVGFVPKKAISVADGVKGTFAYLIGD
SFAKLGLGMIADGTPIFGLTGWKGTFAALDTSAMICIVLLAFVAIAEEKK
IRHAKKLQLAQNQA
>gid:501802  VPA0966  regulatory protein UhpC
MFGFLRSPKFTQPSLSNEQIDQRYRHWRLHIMLGMYIGYAGFYFTRKTFN
YAAPAMITDLGLDKGDLGLIGTLFYITYGCSKFISGTISDRSNPRYFMGL
GLIATGLVNIAFGFSSSLAAFITLWILNAWFQGWGWPSCSKLLTTWYSRS
ERGFLWAIWNTAHNVGGALIPILVGYLTLHYSWREGFILPGIIGVLLGLF
VCWRLRDKPTTMGLPSVGQWRNDALELAQENYGRGLTYREILKSYVFNNK
YIWLLAFSYVLVYIVRTAINDWGNLYLTEQHHYSLINANAALSMFEIGGF
VGSLVAGWGSDKLFGGNRGPMNLLFAIGIFLSVSALWLMPLTNFAFQAAG
LFSIGFFVFGPQMLIGMAAAECSHKDSAGAATGFVGLFAYMGAALSGYPL
ALILEEYHWTGFFITISVCAAVIGLLLLPFLQAQPSRKPLEPKPRL
>gid:501803  VPA0967  putative mannose-6-phosphate isomerase
MNLNTISSHSFFQMNNKIQNYAWGSTSSIHDLFGFSNETNEPQAEVWMGT
HPNGCSEVQVEQNTLPLSELIKQNQPAYLSAETAAKFGDLPFLFKILAAE
HALSIQVHPSKQDAEIGFEKEQNAGIPLNASHRNYKDPNHKPELVYALTS
YQAMNGFRSYDEIIDAFGLCDIDELRAPLDAFKREINSQGLRDFFVHILT
MEGETKERALKQLLAHASRQSEQGTDSEQGTDSDVFQLILDLSTQYPGDV
GLFAPLLLNVITLQPGEAMFLSARTPHAYIKGTGLEIMANSDNVLRAGLT
PKHMDVEELVKCTDFVPKPFNSLVLEPNANGCQSLYPVPVADFSFSILNQ
PNNEVVEANSAEILMAIDADLTLISDNGETLTAAKGQSVFVPAYVGHYRI
QSAGRVARAFN
>gid:501809  VPA0973  putative MFS family transport protein
MENTVVSAASPRVTVPVVALSLYAVASGYLMSLIPLMLGEYNISADYASW
LASVFYGGLLIGAMFIERIVRNVGHRKAFIGCLAAFSLTIVALPAFPNGL
VWLVARFIAGVAVAGVFVIVESWLMSGDEASRAKRLSLYMLSLYGGSALG
QFGIGVLGVSGGVPFVAITTLILMAMLVLMFIDCEQPNSHESTSLSFKQI
AKLNHAAIIGCVVSGLTLGAIYGLMPVELANRKITHQDIGTLMALVILGG
MLVQPMVTTLNKYMSRTVLMAFFCILGIFSIGLTFISTSTAVLAASLFLL
GMATFALYPVAINLGCEGLDERFIVSATQVMLFSYSVGSVAGPVVADKFM
GQVHGLLGYLFAALVATCVYMLLAASKTKQQMAAGL
>gid:501837  VPA0999  alpha-amylase
MKTFKLKRTFLPLTLLLSAPAFAGQNGTMMQYFHWYVPNDGALWTQVESN
APALAENGFTALWLPPAYKGAGGSNDVGYGVYDMYDLGEFDQKGSVRTKY
GTKAQYISAINAAHNNNIQIYGDVVFNHRGGADGKSWVDTKRVDWDNRNI
ELGDKWIEAWVEFNFPGRNDKYSNFHWTWYHFDGVDWDDAGKEKAIFKFK
GEGKAWDWEVSSEKGNYDYLMYADLDMDHPEVKQELKDWGEWYINMTGVD
GFRMDAVKHIKYQYLQEWIDHLRWKTGKELFTVGEYWNYDVNQLHNFITK
TSGSMSLFDAPLHMNFYNASKSGGNYDMRQIMNGTLMKDNPVKAVTLVEN
HDTQPLQALESTVDWWFKPLAYAFILLREEGYPSVFYADYYGAQYSDKGY
NINMAKVPYIEELVTLRKEYAYGKQNSYLDHWDVIGWTREGDAEHPNSMA
VIMSDGPGGTKWMYTGKPSTRYVDKLGIRTEEVWTDANGWAEFPVNGGSV
SVWVGVK
>gid:501858  VPA1016  multidrug resistance protein D
MKTKPSIGLMVVMLMFPQIVETIYSPALGDIAQSFSITYSQAAQTLSIYF
TAFAIGVVVWGLLADKWGRRPTMLVGLLVYGLSALVAMQTDRFDVVMLTR
ALSAFGIAVGSVVTQTMLRDSFSGEELGKVFGVMGIGISVSPVIGMLLGG
QLTALGGYQTVFFTLFVMALGLFVYNVFKLPETQIQKQPLNMGSLLGRML
RDAQIWQSTLLVALYNIALFSYYQLGAFTFEALGFSSSEFGYSGVVLGLS
TFVGSLLNKFLLGKGRTQTSLLWIASILLLAGGFGVFWAQTSIWFLVPML
LVVMAFGIAIPNVLSAALVDYKQQAGSAGAVFGLMYYLLIGAGLGLAGII
QNLGVVQISCAVTVSLVTMSRTKNRRY
>gid:501861  VPA1019  conserved hypothetical protein
MDIIFVRHGVPDFSLADERCMTQLEKDYAPLDRAYLSELHQKLTNAVFDD
AQAIICSPYTRALQTAEILNRRHGFELFVEHDLREWRADTAGGYISLAER
DRRWHEYRELLKLRLPMSDERYEHVTALKARTMAVLERYRQYDKVIVVSH
FNVFEALQGYQEQGLACGDSKIFRL
>gid:501925  VPA1083  ribokinase
MNKLVVLGSVNADHVLQVPSFPRPGETLHGRNYQVIPGGKGANQAVAAAR
LNADIGFIACVGDDSFGINIRENFKMDGIDIAGVKMQPNCPTGIAMIQVS
DSGENSICISAEANAKLTSEAIEPDLERIRQADYLLMQLETPMCGIEKAA
RVAKDAKTNVILNPAPARELSDELLACIDVITPNETEAEVLTGVTVTDNE
SAQEAANVLHGKGIEIVMITLGAKGVWLSQNGRGEIIPGFRVEATDTTAA
GDTFNGAFVTGLLEDLPLESAIKFAHAAAAISVTRFGAQTSIPTREEVDA
FLAEQ
>gid:501926  VPA1084  ribose ABC transporter, periplasmic D-ribose-binding protein
MKKLATLISAALLSSTVSVAAQAQDTMAIVVSTLNNPFFVTMKDGAEAKA
KELGYDLIVLDSQNDPSKELSNIEDLTIRGVKAILINPTDSDAVSNAIRM
ANRSNIPVLTLDRGASRGEVVSHIASDNVVGGEMAGHYIMEKVGEKAKVI
QLEGIAGTSAARERGEGFMTAVKGSDMELLASQPADFDRTKGLNVMENLL
AANPDVQAVFAQNDEMALGALRAVQASGKNVMIVGFDGTEDGIAAVNRGK
LAATIAQQPDLIGALGVETADKVLKGEKVDEYIPVPLKVVTK
>gid:501927  VPA1085  ribose ABC transporter, permease protein
MSTNTMSKPTETSSKKLFTKEWLIEQKSLIALLFLIVVVSFLNPNFFTVD
NILNILRQTSVNAIIAVGMTLVILTAGIDLSVGSVLALCGAFAASLIAME
VPVLIAVPTALLAGAALGAISGIIIAKGKVQAFIATLVTMTLLRGVTMVY
TDGRPISTGFTDTADAFAWFGTGYALGIPVPVWLMVVVFAAAWYLLNHTR
FGRYVYALGGNESATRLSGINVDRVKIGVYAICGMLAALAGIIVTSRLSS
AQPTAGMGYELDAIAAVVLGGTSLMGGKGRIMGTLIGALIIGFLNNALNL
LDVSSYYQMIAKAVVILLAVLVDNKNK
>gid:501928  VPA1086  ribose ABC transporter, ATP-binding protein
MTQAILQLSEIEKAFPGVKALDKASLNVYPGRVMALMGENGAGKSTLMKV
LTGIYHMDAGSIQYQGQPAAFKGPRDSQEAGISIIHQELNLIPELTIAEN
IFLGREFTGSMGRIQWSKMYAEADRLLQRLNVKHSSKTLLGDLSLGEQQM
VEIAKALSFESKVIIMDEPTDALTDTETESLFKVINELREQGCGIVYISH
RLKEIFEICDDITVLRDGKFIGECRVADTDEDGLIEMMVGRKLEEQYPRI
DVKHGETCLEVVGLTGSGVHDVSFTLKRGEILGISGLMGAGRTELMKVIY
GALPSEHGVINLDNKTINPVSPQDGLANGIAYISEDRKGDGLVLGLSVKE
NMSLCALDKLTKGVQIQHGEEVIAVEDFIKLFNIKTPTRDQIIGNLSGGN
QQKVAIAKGLMTKPKVLILDEPTRGVDVGAKKEIYQLINKFKADGMSIIL
VSSEMPEVLGMSDRILVMHEGRITGEFDAKDADQEKLLACAVGKKINEEA
A
>gid:501929  VPA1087  ribose ABC transporter protein
MKKSTLINSGISYLVATLGHTDEITICDAGLPIPDHVQRIDLALTHGVPS
FLDTVRVILSESQIEGVIIAEEFSDVSPVLHEALLKELSKESEETGKSIE
IKYVSHEAFKARTEQSRAVVRTGECTPYANVIFQAGVVF
>gid:502020  VPA1177  putative chitinase A
MKKTLLAALIMGITGAAHAEQKVVAGYFADWQYANAENPYTVKDIPADKL
THVIYAFLSMCGPHTGASETVQNLVAKQCEGKDPYTAIIVDTEAALEKNF
GAVSVNVPYKGHFAQLAEMKKQHPDLKILPSFGGWTMSEPFHAMAKNKQA
MDQFSKSAVELIAQYDFFDGIDLDWEYPGGGGLTTSPWNPDTKLSDEQKA
SEREAFTYLVKTMRAELDELTNQTKREYELSTAVGVGPKAAGIDWKAAEP
YLTNMFAMTYDFLGGWGQQTGHTTNLHATERSWWGMGADVFINQMIELGI
PSEKLVIGTTFYGRGWQGTKDFSGGLPTQDLVSEQGAQFGTGENGYFMFW
DLVKNYGAKQGYEYNYDEQSQAPYLWNPEKKVFISYEDQRSIKAKANWAK
QANLGGIFTWELSGDPKGELVEVMYQEMQK
>gid:502023  VPA1180  transaldolase B
MSNKLEQLRKLTTVVADTGEIDAIKKYQPEDATTNPSLILKAAQIAEYAP
LIDASIEYAKAQSNDKAQQVQDTCDMLAVNIGKEILKTIPGRISTEVDAR
LSYDMEGSVAKARQLVKMYNDAGITNDRILIKLASTWEGIRAAEILEKEG
INCNLTLLFSFAQARACAEAGVFLISPFVGRIMDWYKAKEGRDFEASEDP
GVLSVTKIYNYYKEYGYKTVVMGASFRNIGEILELAGCDRLTIAPALLAE
LEAAEGEVVEKLVDSKGAAERPAPMTHAEFLWEHNQDPMAVEKLAEGIRN
FAVDQGKLEAMIEAKL
>gid:502024  VPA1181  transketolase 1
MDRKYLANAIRALSMDGVQQANSGHPGAPMGMADIAEVLWRSHLNHNPSN
PEWADRDRFVLSNGHGSMLIYSLLHLSGYELSIDDLKNFRQLHSKTPGHP
EYGYAPGIETTTGPLGQGITNAVGMAMAEKALAAQFNKEGHDIVDHFTYV
FMGDGCLMEGISHEACSLAGTLGLGKLIAFWDDNGISIDGHVEGWFSDDT
PKRFEAYGWHVIPAVDGHDADAINAAIEAAKADPRPTLICTKTIIGFGSP
NKSGSHDCHGAPLGAEEIAATRKELGWEHGPFEIPQEVYAEWSAKETGAA
KEAAWNEKFAAYEAAYPELAAEFKRRVNGELPAEWEEKASQIIADLQANP
ANIASRKASQNALEAFGALLPEFMGGSADLAPSNLTMWSGSKSLEANDFS
GNYIHYGVREFGMTAIMNGIALHGGFVPYGATFLMFMEYARNAMRMAALM
KIQNIQVYTHDSIGLGEDGPTHQPVEQIASLRLTPNMNTWRPCDQVESAV
AWKLAIERKDAPTALIFSRQNLAQQPRSAEQVADIAKGGYILKDSEGKPE
LILIATGSEVELAVKAAEQLTAEGKKVRVVSMPSTDAFDKQDADYREAVL
PSDVTARIAIEAGIADFWYKYVGFDGRIIGMTTFGESAPADQLFEMFGFT
VENVVNTAKELLA
>gid:502027  VPA1184  putative drug transport transmembrane protein
MDLNRNVWLLSLCQALLMTGNILLISVIALIGKTLAPSPSFITLPVALQF
LGLMAATIPASLIMGKLGRRLGFSLGNLIGIVGASLATYALSQQTFYLFC
FSTFLLGVGIGFGTLYRFAAIEVCEESARHRAISISMAGGVLAAILGPNL
AVYSQQWSDDGLYTSAFSVLIVLYITALVLLQTIRFPPAHTQLSHVKADT
ISDIIRRPNFMIAVLAAMVAYAVMNILMTATPLAMIGCGFDFDKAAGVIE
WHVLGMFAPAFITGRLIEQFGAKKMILAGGVLFIACIGINIHGVSIWHFS
LALVLLGVGWNFMFIAATGLFSQSYEAKNRSKAQAFNEFFVFSCVTTTAL
LSGWLESTVGWQNLNLYVLPFVLLVIVIFAMKTDNKTESQIA
>gid:502058  VPA1215  hypothetical protein
MDATTMILGYAAILVTVLLWSGFFISLKGGAISALQPADIALVRFLVPSL
ILLPFVMKHKAALKVVPNKYLTGIVLGSGLPYLLVAGTAMHFAPVAHGSA
LIPGTLPLFVSAIAVLFYQQSLSHHRIIGLSTVLLGIFVFLLSNIGEEYN
WSQLQGHAMFLVGSLMWAVFTISARVANLNAYVCAGFVAIVSLLMLIIAV
GFGWIDSYLAVTPISSWPWEELFSHAMLQGVGAGLIASFTFIYAIKIIGA
EASAAFGSLTPVVATLLAVPIFGEQPDSLTWIALILVTCGSVVASQIFMK
HELTQTYRPPLHR
>gid:502060  VPA1217  hypothetical protein
MKLWDHPMSENDFRQCLRIATGATIGFTLCKLFGWNYGVFFTVTPMLLLG
MVPVVNLHASRQLIFSAVVCGLEVGILGGLFGSHPVLMTLIAFGLFLYKF
ACMSKGSLFLFGANSVLSLSIMLHFASYPTTDLNDLIFSNLQANVLSIIV
AYLVTFLIPDAEPRQPLPKPSQAKQSHRMRHEALMGASIATMSFLVFQIF
DLNDSMSAQATTLLLLFPMHWNGALGYARKRAMGTLLGVTFGIVGQLILY
DWSNTLLFIVPLLWIGAMIFSYMHVKESSGSGAGFGGLTTLGILFGQYLT
PDGDLIFSALYRVSSILFAIVVTLLVTYAVHRLLNSFAATRFSQS
>gid:502064  VPA1221  LuxP protein
MNKALVLSLISIAGMSPASQASQVLNGYWAYQEFLNEFPEQKHLTDALAA
AVRDDPVPIAPEKRHPLKISVVYPGQQISDYWIRNIDAFEKRLDKLNIDY
QINQVFTRPNADIKQQSLSLMEALKSNSDYLIFTLDTTRHRKFVEHVLDS
TKTKLILQNITTPVREWETRQPFMYVGFDHAEGSRELAVEFGKQFPKNTH
YSVLYFSEGYISDIRGNTFIHQVNQDSQFELQSAYYTKATKQSGYEAAKA
SLKKYPDVEFIYACSTDVALGAVEALSELGREDVMINGWGGGSAELDAIL
KGELDITVMRMNDDTGIAMAEAIKWDLEGKPVPTVYSGDFEVVTKSDSPE
RIEALRKRAFRYSDN
>gid:502073  VPA1230  glyceraldehyde 3-phosphate dehydrogenase
MSPEKYLQDWQTSQTIAESISPLIGKLYRQKGIEVVLFGKTLINATTIDI
LKTHRVARRYTGSPLSLEHTMPIIQALCEMSISSCRVDVGQLATKYWNEH
EDTAALNDFLQTALQGARDADSSLAARDVVLYGFGRIGRLLTRLLIEKSG
PGYPLRLRAIVVRGGKKGDLEKRASLLRRDSVHGQFNGSIVIDEERKALI
VNGNYIQIIYANNPSDVDYSVYGINNALVVDNTGVWRDSEGLSQHLACKG
AEKVLLTAPGKGDIKNVVFGVNESVIQEDDTIISAASCTTNAITPVLKAL
NDKYGVRSGHIETVHSYTNDQNLIDNFHSGDRRGRSASLNMVLTSTGAAK
AVAKALPELAGKLTGNAIRVPTPNVSMAVANLNLGTDVDRDSLNDYLREM
ALNSELSAQIDYTDSTEIVSTDLVGSRHAGVVDGQATIAQDKRCVLYIWY
DNEFGYSCQVVHCMEQMMGVRYQTFPR
>gid:502127  VPA1283  putative MFS transporter
MSIFRFPVLVWLGIGILIICLGIRQSFGIFMMPISDYFQTGREFFSFAIA
LQNLLFGVFQPFVGMASDRWGAKRIIILGAFSYALGLYLTSIAIEPTMMY
LSLGILVGFGLSATSYVIVLGAVAKVVPAQHAAKAFGLTTAAGSFGMFAM
IPGAQALLSDFGWQGALQAFAVLCSFMVMFALFMRTAKPQASNHANVQED
TQTLKEVLKEAFSHRGYWLIHAGFFVCGFHVMFIATHLPSYLADKDLPAS
TAAMALAYVGIFNIFGSYFWGVMADRFNKRHVMSALYLIRTVVIGAFVTL
PVTEHTAVIFGGAIGFCWLGTVPLTSGLVRQIFGARYLSTLYGLVFFTHQ
VGSFLGAWVGGRIYDYYGSYDPIWWSTVVLALLAALIHLPINDKPVSRLN
LATA
>gid:502189  VPA1341  putative Spa29, component of the Mxi-Spa secretion machinery
MQQILFPNWMLFAGFYLFLRIFNPTRLYLDNTSSLAIAIMLAIGLEREHL
AQPATLLWVIAAVTFAFVCSVPYWLSGIVGCVLQQMLLLNEQSVQDHRFT
DESEALAKLCSLVFVAYALENGAVFKPLFDLILSRHLVLPEVSFSSLYQT
VVENMQMILIISGKYIILMLVITMCCGYLDLFFKKASLSMFVTPNIKSIV
IVILLNIWLFHDQFYVFNKMMKSLGYE
>gid:502235  VPA1384  hypothetical protein
MDDLSSAVDAVAVTIGVALSAEVKIGFMEQYPFKYALIGCLGLATYLYCL
LKIQNVIEIRTAHRFATANVSYFGITLCFLTLIIVPFVPSIVANVVWGAA
LFSQILIPVRTAFKVLTREAKQALD
>gid:502236  VPA1385  putative integral membrane protein
MLYSNQAVKGALNNERFLPRFGYMAECFALLLLIVAGEGFFKPVITLAEK
GIDDVVGDVFVNYAFGGLSIFVLCWIYFDFVGNSKPLGNAPNTFIKWTIS
HLLLMLSLSR
>gid:502250  VPA1399  maltose ABC transporter, permease protein
MAMVQGKSLKYRVWATHIAMWAFLALIIFPLLMIIAISFREGNFATGSLI
PDNPTLDHWKLALGFSITNADGTVTPPPFPVMTWLWNSVKVGGISAILIV
ALSTTSAYAFARMKFKGKNTILKAMMIFQMFPAVLALVALYALFDKLGQY
IPFLGLNTHGGLIFAYLGGIALHVWTIKGYFESIDSSLEEAAALDGATPW
QAFRLVLLPLSVPILAVVFILSFIMVIGEVPVASLLLSDVDSYTLAVGMQ
QYLYPQNYLWGDFAAAAVLSAVPITAVFLLAQRWLVGGLTAGGVKG
>gid:502251  VPA1400  maltose ABC transporter, permease protein
MQSVQGTNAMTAPEASLPSSKKVFIKWSLLGTVGILNGYATILMYSRGEI
AFALLTIILTALALFIFGSKKTYAHRYIYPGIAGMILFILFPLAYTIGLA
FTNYSAKNQLSFDRAQSVLLDRTYQSGDSYPFTLYNTDQGHQIVVEKDGE
LLATPVFQLQGFSETDLDLAPITEAAGDKEPIKTIVKNRTALSSVDLHLP
NGDDIRMSGLRKFAAVVPLYTLQEDGETLYNNRTQETLRPNMEVGYYQPV
DENGQFVGSTVSPGFVVNIGTHNFERVWKDDGIKEPFISIFIWTIVFSAL
TVVCTLVIGLVLASVVQWEALKGRSIYRLLLILPYAVPAFISILIFKGLF
NQSFGEINMLLEGLFGISPAWFSDPFMAKTMILIVNTWLGFPYMMILCMG
LLKAIPDDLYEASAIDGANFITNFTRITMPMMLKPLTPLLIASFAFNFNN
FVLIQLLTGGGPNMIGTSEPAGYTDLLVSYTYRIAFEGAGGQDFGLASAV
ATLIFLLVGALALINLRVTKVAQD
>gid:502252  VPA1401  maltose ABC transporter, periplasmic maltose-binding protein
MKKLSAVALGTLVALGSFGANAAIEEGQLTIWINGDKGYNGLAEVGKKFE
EDTGIKVTVAHPDGLQDKFPQTAATGDGPDIVFWAHDRFGGYAEAGLLAE
IKPSKAIQEGIVDFAWDAVRYDGKLIGYPVAVESLSLIYNKDLVPNPPKS
WEEVAALDAKLKKDGKSAIMWNLKEPYFTWPLMAADGGYAFKYTSEGYDV
KDAGIAKEGVKDAMNFVKGLVDKGVISADMDYSVSESAFNQGKAAMTING
PWSWGNIEKSGINYGVTTLPKFQGQSSKPFVGVLTAGISTASPNKDLAVE
FLENYLLTNDGLRMVNNDKPLGAVALNSFQRELDSDTRIAATMDNAMNGE
IMPNIPQMNAFWGAAKNAIINVVDGRQTVDAALADAEKQMTK
>gid:502253  VPA1402  maltose/maltodextrin ABC transporter, ATP-binding protein
MASVTLKNVCKAYGDVLISKNVDLQIDEGEFVVFVGPSGCGKSTLLRCIA
GLEDITSGDLYIGDQRMNDVEPSKRGVGMVFQSYALYPHLNLYDNMSFGL
KLAKADKAEIDKRVEHAAEILQLGHLLERQPKALSGGQRQRVAIGRTLVS
QPNVFLLDEPLSNLDAALRVNMRAQITKLQRQLGCTMIYVTHDQVEAMTM
ADKIVVLDGGYVSQVGKPLELYHYPQNRFVAGFIGSPKMNFMSVFIDEVE
SERVKVQLSNGVSFWIPVDGTTVNRGDRMSLGIRPEHLLSATEADATIHG
EVMIVEKLGNETQVYLNLEGADADVIYRQPDTLAVDTGDKLEIGIPAHRC
HLFHSDGRACKRLFKENGVDFE
>gid:502264  VPA1413  hypothetical protein
MTSTIARLGFISISLLTIGLSLWKSSELNHAVYLNMENYVGGSSTLHFTF
SMLIGFLAVFTFPRFTHATKMDAFGIRLLFCLLLIISAEEFSQLFIESRS
FSFDDLSTNWIGMILGYFGAKAITLFRTSRSRA
>gid:502271  VPA1420  PTS system, fructose-specific IIABC component
MDITNLIELETICLDLKAQTKDEALKELVEMLEAAGKLNSQSQFLADIWK
REEIGNTGFDDGIAIPHAKSDAVAKPAVAVGISRNGIDYGAEDGELSDVF
FMLASPDGDDHHHIEVLAQISTKIIEDGFVEKLKQAQSREEALEMLTDIQ
TQSNEFLPTSLEFASEPLSPWAQKLGRIKEHLLFGTSHMIPFIVAGGVLL
SLSVMISGHGGVPQEGILADIAQMGIAGLTLFTAVLGGYIAYSIADKPGL
APGMIGSWIAVSHYNTGFLGAIVVGFFAGLVVWLLKKIQLPDSMSSLGSI
FIYPLVGTFVTCGAVMWVIGAPIASAMTTMNEVLTGMAGSGKVMLGTVLG
AMTAFDMGGPINKVATLFAQTQVNTQPWLMGGVGIAICTPPLGMALATFL
APSKFKRDEREAGKAAGIMGMIGISEGAIPFAAGDPARVLPAIVAGGIVG
NVIGFMFHVMNHAPWGGWIVLPVVDGKIGYIIGTIAGSVTTALIVIALKK
TVTEDESYTGHSQVYGSVQGEGEADVLAVTSCPSGVAHTFLAAKSLEKAA
CALGIKIKVETQGANGVINRITEKDIEKAKFVIFAHDVAIKEPERFRKIK
VLDVTTKDAMLNATALLQARRVS
>gid:502272  VPA1421  PTS system, fructose-specific IIB component
MKIVAVTACPTGIAHTYMAADALMKAAPKHNVQIKVETQGAMGIENQLTP
HDIAQADRVLIVSDIEIEQPGRFEGTRKIQIPIEEVLLNVDKVFLVHCRD
>gid:502273  VPA1422  putative PTS system, nitrogen regulatory IIA component
MNEYQITFFVDNANASAHLAQPLNRVAKKFKSTLHIINVTQNRVAELTKS
VAILQAGLQQGDLCQITAIGIDAELACFVIKDMIAEHFTVVGSHINYEFS
SQLAERLPQICPPCEIKWHYAKAHTALTKFECLKGLAQLIHPIHPDELIL
AFIKREERSSTCVTPGIALPHVMFSGVDHISIAVIANDKSMDWASKMGDV
HLAIALVMPEKPTREQIIAATNLTRNLLTDQMAERLLLTKSSVDLQALLM
YAMSRLLA
>gid:502275  VPA1424  PTS system, fructose-specific IIABC component
MITKLINEDLIKLDLKASSKEDVFKELVAVLHAQGRISDQTQFLADIKAR
EELGNTGFEDGVAIPHAKSAAVIEPAVVIGVSKSGIEYGAEDGLPSKLFF
MIASPDGGDNHHIEVLAELSSKLIEDGFIDAFLDAANSQDALALLLAKEE
PQPVTDAPANQGFIIGVTGCPAGVAHTYLAAEALEKGAAAMGYEIKVETN
GSIGVKNSPTAEEIERADAIIVACDKQVDMNRFAGKRVVKTNVKAPIRDA
QGLINEALNAPTYQAESNGNTQASVADKASQARSDLYRYLMNGVSHMIPF
VVTGGLLIALALAVGGQPSEAGMAIPEGSMWNQILNVGVVAFTLMIPILA
GYIAYAIADRPALAPGLIGGWIANNGSFYGADAGTGFIGAIIAGLLVGYF
VKWITSINYHKFIQPLVPIMIAPITGSLFIAGLFIFVIGAPIASLMDGLT
ALLTSMSTGNVVLLGIVLGGMAGFDMGGPFNKVAFLFSVGMIASGQTQFM
GAMACAIPVAPLGMALATALGRKFDLFEESETEAGKAAGAMGLVGISEGA
IPFAAQDPMSVIPANVLGSMVAAVMAFSFGITNSVAHGGPVVALLGAMNH
PVLALICMTAGATVTAVTCVTLKKVRKAKMMQAAA
>gid:502276  VPA1425  mannose-6-phosphate isomerase
MSDLTMSDTQTIQTQAAHPTFFLMNNVIQNYAWGSTTSVNQLFGIENPTG
EPQAEVWMGAHPNGCSMVTVNGEETKLSSLIAQDMNAFLSEEVANRFGEL
PYLFKVLAAEKALSIQVHPNKQQAELGFALEEKQGIPLTAANRNYKDPNH
KPELVYALTEYQAMNGFRPTSEIISFFSELAIPELQGLVDDLIANQTPTG
LATFFSGLLSLEGEQKGMALTVLLAQARITDLPLFNLILELETQYSGDIG
LFAPLLLNVITLKPGEAMFLDAETPHAYLKGTGLEIMANSDNVLRAGLTP
KYMDVKELVACARFEEKPFDNLLLAPIENDDMLEYPIPVDDFKFAIVKQA
NQRTLDVRTAEILLPLDSPLVITHANGETRVVDKGQSVFIPAYAKQYTLN
CEGRVARAYS
>gid:502280  VPA1429  hypothetical protein
MQTRRELFFAPFQRLAVIAEQWRAGSKSYLTDLASIALLLLPLTLSNALA
ILLGHAFRVAGLGDVSLLLFHLSDILINLYPTAFCVVAAYYLSHKANVSS
VVLIIYSLIMFYLVSIENESLSATYTLPNNSLLALISAMMSYLYCKHLRI
QLLEPQALDFTSRLFKDVLHFFVFVLVAVSLSHVTAAIMVWFSGAVRSIG
VDPLTLEGGLIYQTVLGLLGATGINAHNMLFAIKQQIYAATEANMAAWQA
GEASLNVISQGFYDAFLSMGGSGNSVCLLLCILIFARERNHIMLALAAAP
LVMFNINEVLLFGLPIIFNPILIIPFVLVPLVSFVITYASIASGMIDPVE
KIVNWMTPPLISGYVAMGNHIQGTILQLIVVAAGVLIYRPFYLAYAGKHA
SQFGLNNALNGIEQSLFKSLLNSVKDSNIYSINKSSAQKRLTSILREGEL
VMFYQKLQSTHDEKVFSYEALIRYIDKEGKLCPPTFISDFQMLDAMPLLD
KLVIEKVLSDMKTMSLSPSRRVAINISVSTIEQADFVQHLQGRLEHYGVS
PDWLEIEITEEAVLNDKVSLTNTMIALQACGIRIAMDDFGTGYASFPHLL
KYPFDKIKLDRSLLLDATDEKGRELYRIVAKLGHIANCEVVAEGVETQAE
YEFVAQCGVDKVQGFYLAKPMPRQDLSDERE
>gid:502335  VPA1484  hypothetical protein
MNTSSHGWRTPQNFLLLISIIVPIAFSTWMALLNNFVIEKANFDGADIGL
LQSVREIPGFLAFTAVFVLLFIREQRFMLVSLAMLTLGTALTGYFPTLYG
LLFTTLLMSTGFHYFETLKQSLSLQWLSKEEAPEMLGKFISVGALASLFT
YGAIWILLEQLKFDFKTVYLLAGGVGFVLIIVMALAFPQFKTAVPQNKKL
VLRKRYWLYYALTFMSGARRQIFTVFAGFLMVEKFGYSAADITLLFLINY
LFNFLFAKRIGRFIGVVGERKALTFEYVGLIFVFVGYGLVQTAEWAAALY
VVDHLFFALALAIKTYFQKIADPADMASTAGVAFTINHIAAVVIPVTFGM
IWLVSPSSVFYIGAGMAAVSLLLSLNIPAKPEEGNETRLLRWG
>gid:502342  VPA1491  hypothetical protein
MRNMITSARDGNLPLQSKRAPERQATTLNSTDAMAMVEHGSEVTLNVTTP
VGTKFITTSTFVGCHSNNTALIEVPNISDEDLKFYFQEGFWINVKAYSHR
GEGAVIPFRAQLQHRLGDPYPILVLSLPNTMQVFQLRKEVRYEVNLKARV
RLDEYRSECEIRDLSRSGCRFVTSPMSRPLQVGDRITLDLTMPSDGRMLA
PLNGRICNLQKSTHYARYGMEFDEVGKTNAKSLLSHLKFDGTKLKLK
>gid:502380  VPA1529  hypothetical protein
MNHVHKPIVFMLMSTLSLSVTGLLAKQLSEALSVTMFSFLRFFLPAVILL
LVLIPKGIKLPKSTELKPTLLRALCIGLSQLCFIASLQTLTLVESVVLFA
TGPLFMPVIEKLVWHGKIRASIVFGIVMAFSGVVLLAGTEGEFTLRYDLL
LGLAGGLFNSGSQLTLYKVSKSNMSPLEINFWAFSFAALFILPLALINDG
SGLLGAHSFSLSVEPSVLWLLVMSMLIINTQVFRAKAYQLASSGSQLAPL
IFTNLLFTAVWQSLFFADVMSRTQIAGMGLIVLATVLNGCWDVLVKHHQS
KALQTRTS
>gid:502416  VPA1564  hypothetical protein
MQTILGASGQIGRELALSLKRDFTSDIRLVSRNPHRVNETDQLVKADLLD
AKQTSDAVKGSSVVYLTAGLPMDTQLWVEQWPTMMRNVIAACKTHQAKLV
YFDNTYMYPQTDTPQQEDAPFQPNGEKGRIRAVITDMLLESMNKGEIEAV
ICRAPEFYGPGKTQSITNSAIIDNLLNQKSAKVFLRDDTKRSLIYTPDAS
RAMALIGNTPDAYGQTWHLPCDDRRLTYREFIAVAAKVFNVQPKYKVIKR
WQLWLAGRFNQTIRDAAELLPRYESDNLFVSDKFQARFPDFQITTFEQGL
TTIQQEKANDLKPL
>gid:502420  VPA1569  putative transaldolase
MIELYLDTADVAEVKRFNQCLPLKGVTTNPSILAKSKQGLNQTLAGMQEA
LGGTPRFHAQVVSTTVEGMVEEARQIHELPYDMVIKVPATETGLSAIKLM
KKEGIQVLATAIYSAQQGFLAALCGADYLAPYVNRIDAMNGNGVEVVADL
QLLLDQNQLPAKILAASFKNTQQAMEVMKLGIEAITLPVDVAAQMFSHPA
VQPAVDQFDKDWKSTFGNKLSFES
>gid:502425  VPA1574  putative membrane transport protein
MSRFLLCSFALVLLYPTAIDLYLVGLPQIASDLNASESQLHIAFSVYLAG
MATTMLFAGKIADSVGRKPIAVVGAMIFVLASFLGGMAEQPNTFLIARFC
QGIGAGSCYVVAFAILRDTLDDERRAKVLSMLNGITCIIPVIAPVIGHLI
MLKFPWPSLFTTMAGMGILVSVLAIFVLKESLPSQQGEEQTTPESHQETF
FERFFISRLIITALGVTTILTFVNASPIVVMSMLGFDRGGYSSIMAGTAM
ISMLISFSAPLALGIFKQRTLMMTSQVLLACAAIVLSAAHFHDGQSHYYV
FGLGLICAGFACGFGVAMSQALSPFSQQAGVASSLLGIAQVCSSAFYIWF
MGFIGVSALNMLVFILVLGSVISLALILLIPKPVHDTHYEEIPSAT
>gid:502427  VPA1576  putative transmembrane protein
MSTFLLTAITMLAFAANSLLCRLALAEGLIDAGSFTLVRLISGAITLIAL
LVVRGQWKTDRPTSRFRFFAGVALFGYAALFSFAYLQLATGTGALLLFGA
VQLTLLVIYWWQGERFQFLEIIGIGLSIVGFVWLMLPSTTRPDISSALLM
LISGVCWAAFTALGKQAPSPSSGITWGFIAASMIGILLSPLMLSSIHLSL
SGILLAITSGAIASGLGYTLWYQVMRKLSLLQAAVSQLSVPAIALLLGTV
VLHESLSLHTLLTSGIILGGIALVFLSRSKKTSKQLASR
>gid:502444  VPA1593  putative cyclodextrin glucanotransferase
MNKIKILPLAIALALSGCGSDETTPIDTGSHVASPDWQDQIIYFLMIDRF
NDGDSALNDQGQNEFDPTSDKKFSGGDLVGVSDKLSYIEDLGATSIWITP
PVANQWWDAEQNYGGYHGYWARDFQKVDEHFGDMESYQALAREVHARNMF
LIQDIVTNHVGNFFTYDDPYSYDPSLPCQGFRLIKNALPAGQELPYPLNM
NECKTDGTGSYHWTPTITDHNDPVQEKTWQLSDLDDLNTSDPEVRAYLKE
SYRKWIREVGVDGFRIDTVKFVEHDFWSDFLHADDGVMTQAVDTGRDNFL
TFGEVFETSTPYHTEGEEKMLTYIGESGSPKQLTSVLNFPLQATMTRVFA
SGQPTDYLRFRLEKMMEMFPNPYIMPNFIDNHDMPRFLSQGSVNDMKQAL
ITMMSVPGIPVIYQGTEQAMSAARDAMFAGGYREDGNYVDSFDQNSEMYL
FIQELAKLRTENKVMTRGEIKVIGSDKAGAGVFAFTRTLDNDEVLVVMNT
SNSPMLMNQLDVEQAGGTVFKQQIMSNWADAPEQLVADENGHVTLELPAK
SAVIYSKTSSNQSVNTPDLNIQLAQDWEGKTITGDIVIAGSANANEKLNL
VVDGNLETAQTITVGADGQFSVTLSTRHFAIGEQQHRFAIYSTEKKAGIE
DVNFVSNLSWSNTPDDTIDDAGDAQDGVGGPNGNYSLPTDPTFDKDNSQL
AINKAEVFTVGSNVRLTFTMDKITDTWLPPNGFDHVGFTIFIDLPEEAAT
NLSELPKINASMPNGTWSRNAVVFGWQSSIYNTKGANATTWGEAVTPAPT
VTVDKANNTISMDFASDALGRPESLDGIRFYVTTWDLDGLSATYRPLEQD
KGPWNFSGGASDESKIWDDLPIITLSE
>gid:502456  VPA1605  hypothetical protein
MEDKEMKTNRTFLTVHGVIYTVFAFALFFVPTMIWPMYGVQINDQYALFL
SQHTSIFLGGIAAVSLMLRDVESGKTAKQLFKALLITNGLGAVITTYASI
TGVFVGFGWSDPIFFVSLSLLTYKQLRVQ
>gid:502467  VPA1616  alpha-amylase
MKLNLITTTLLLASASAIAEPNITISTTTNSRDFPLSAEQPLVVPLTKDG
YTLKITGVEGDCVAPDGQKVKFNKPIALNCGKPTELPLKVRFTGDYSFAY
DDAAKTLLFKREPKKAAKTEFKRPIPQVQCEVYQGGEVTIAVGDSFPEGT
KLRDAYSGQMVEVKEQKVSLTPSKDSGGLVLLEPVQKTKEAVLFDYRNAN
IYFVMVDRFNNADASNDNSYGRKKDGKDEVGTFHGGDLKGVIEKLDYIKS
LGTDAIWLSPIVEQVHGFVGGGDSGSFPFYAYHGYWTRDFTKIDENFGNE
EDLKTLVEEAHKRGLKVLMDAVINHSGYSTLADLQFDGIDVLKPNAELPK
KWGDWQPKAGENWHSYHQNIDYQSLNWAKWWGGDWVRTGLPGYPAPGSSD
ITMSLAGLPDFITELDKAVKPAQWLLDNPGTRVEARDNYTVSDYLIEWQT
DWVKRFGIDGYRVDTVKHVEGEVWKRLKEEASNSLEQWRKENGKSGQPFW
MMGEVWGHTAYRSPYFDDGFDALINFDMQKKLDKGAACFSQMADTYQSYA
DTIANEKDFNPVSYMSSHDTELFFSRFKDYGMQRNAANALLLSPGAVQVY
YGDEVGRNIGPYADDFHQGTRSDMVWKLSDDKQALLKHWQTLGQFRQAHP
AIGAGQHRVIEQEGAYVFSRSLGNDKVVVAFVGRDK
>gid:502469  VPA1618  1,4-alpha-glucan branching enzyme
MSSQRWLWRNQHSVQTNIGSREKDLKITKTKKIKKKHERAYELLAEAAYS
DPFAALGPFIDDGEGSLRVWMPGANKVELLVNGEPRVALERDGDSGFILK
EQRDLHLTHYRLAVDWNGVEQIIDDPYQYHNIYQEYEHLHTPKDMYHYMG
AHFVTLERGGENISGVRFLVYAPHASAVSLVGCFNQWDGRRHPMQRLDYG
IWGLFIPGLEEGVQYKFELKGPNGEGLPHKQDPWGFYSEQYPSFASITYD
HKRYQWQDAKWQNRAVTQKRDEALSFYELHAGSWKRDGKGDFLNYRELAE
QLVPYLVDMGYTHVELMPVSEHPFYGSWGYQPVGLFAPTSRYGSPDDFKF
FVDACHQAGIGVVLDWVPAHFPSDDHGLANFDGTPLFHDPDPRRGWHQDW
NSYIYDLGREHVRRFLVSNALYWFEQFHIDGIRVDAVASMLYLDYSRSHD
QWVPNVDGGNENYDAIATLKWMNEEVYKHFPNAMTIAEESTAFPGVSAPT
FMGGLGFGFKWNMGWMHDSLSYVKEDPVHRKYHHNTITFPLVYAHSENYV
LSLSHDEVVYGKGSIHNKMPGDEWQQTANLRAYYGYMYGQPGKKLNFMGA
EIGQTAEWNHDDQLQWFLLEYERHQGVQKLMRDLNHLYRNEAAMHDQDCV
PAGFEWRLQDEADASILAHERISKEGERILIITNFTPVPHERFRLGVPNV
GQYELLLNTDDSKYGGSDFKVLTSVKTEKVESESLPQSLELRLPPLSTVF
YKLHK
>gid:502470  VPA1619  4-alpha-glucanotransferase
MKEQTALKKVAEMARLADSYVSAWGDEAKVSDETLRRLLTSLGYDTSSDE
KLLASAEKKHKKDVLAPVLVLRDGEPVEVELNLGTSARESEFSWRLETEQ
GEVLEGYLQSQIVRDERAEGGPLVFALPKNLAWGYHKLIISRKRRKTPYE
MSLIITPKACFKQEDLNQHKKLWGPSIQLYTLRTQHNWGIGDFGDLKQLV
SDIASRGGDFIGLNPIHSLFPANPEGASPYSPSSRRWLNIMYIDVSSVPE
FALSAEAQQRVGSAEFQQRLQKARDSHWVNYTEVSQLKMSVLPLLFSEFK
ARHLDKNTDRARAFLDFVEKGGESLLHQAAFDALHADLHAEDSGVWGWPV
FPEKYRTFDAAGTQKYIKDNQDRVHLYMYLQWIADDQIKEAQALAEEKGM
AVGLYRDLAVGVADSGSETWADEGNLVLDASIGAPPDILGPLGQNWGLPP
LNPQVLEATGYDAYIKLLRANMKHCGALRIDHVLGLLRLWWIPKGEKATE
GAYLYYPVEDMLAILALESHRHQCSVIGEDLGTVPDEIVDILRDAGVHSY
KVFFFETSKEDGGFISPKHYAEQSMAALCTHDMPTLRGFWHCDDLKMGRE
IGLYPDEKQLEGLFADRLKCKQGILDSVRWHGYLPEGIGHDAQFVPMDSY
LSEALQLHVAAGDSALLSVQLEDWLEMDQPVNIPGTVDEYPNWRRKLSMN
LDEIFSREDVNRISKRLTEVRAQASK
>gid:502471  VPA1620  maltodextrin phosphorylase
MKPTQQKQFDKKSFQDSVKKHLSVTYAHTVENADSRAWYLAMGRALAEFT
TFDLLATETDPRIQQAKSVNYLSLEFLIGRLTGNNLISMGLYEQVTEAMA
ELGHNLTDLLEEERDPSLGNGGLGRLAACFMDSCAAQEFPTVGYGLHYEY
GLFKQSFKDGRQQEAPDAWRGVEGYPWEVARPELAQEIGFYGHVEVVNVD
GKEVRKWVPGMSVKAMPWDLPIVGYESDTVYPLRLWECQAIAPFSLASFN
NGDYFEAQHALIDAGNITKVLYPNDNHEKGKTLRLMQQYFHSAASVRDIL
RRHEAAGYSLADLPKQETIQLNDTHPTIAIPELMRILMDEKGLTWEAAWE
ISSKTFAYTNHTLLPEALETWPESLIQHLLPRHMEIIYEINHRFLQDVRA
MWPGDVAKQQKLSIIEEGFHRMVRMANLCVIGSYAVNGVAALHSELVKKD
LFPEFHEMYPTRLHNVTNGITPRRWLKFCNPGLSQLITEKVGAEWPAKLE
QLEGIAKYATDATFQKEFMAVKKENKERLANWVKEHMGIELDTNAIFDVQ
IKRLHEYKRQHLDLLHVLSLYHRILNEPGFECTPRVVFFAAKAAPGYHLA
KEIIFAINKIADKVNNDPRIGNKLKVVFIPDYRVSMAEIIIPAADVSQQI
SLAGKEASGTGNMKMALNGALTIGTMDGANVEIREEVGDENIYIFGLDVE
GVKALKAQGYNPFDYYNADHLLKASMDLLLGEEFTPGQPGLLRATYDSLL
DGGDPYLCLADFASYVKAHEEMGKQYKDQAGWAKKAILNTALVGKFTSDR
SIRDYVNNIWKLEAVHR
>gid:502479  VPA1628  hypothetical protein
MFQALKRVFSFLTQTNPNVEQDVDTIIAAIGGLDNVVETGACATRLRLTL
RSTAVVDKEALKKHGAHGVVVLDERHIQIIYGLKANTYSQIMEERMTS
>gid:502489  VPA1638  putative pullulanase precursor
MDNKTFKLSTIAKTVLPLISIAVISGCGSDSTSDDTTNPGSGLYPAGENE
VVIYYKRDIASASTASDYEGWGLHLWNGEGCTSTDLEAMGIAGTGTDWSA
PRPFDGINDTYGAYYVLKVNPDASDPHECMNFILHKGDEKAFGSSNSKVE
LTKIGESKGLFGFHGSSELYYEPIEERPVDIDGQKAHWLDANTIAWEAAA
NADSMKLFYSLTNDIKMDEDKQISGGTAVELTKAGDLSDGLKSRFRHLAS
LQAAGIDVDDATLRTILKSQIVMVAYNANGDVISATEVQKPGVLDAVFAD
SKAGNAISQELGAIVEGGAATFKLWAPTAQDVALIIYDENLKEETTVAMK
EDSATGIWVSEAQSNVVNKYYRYQVKVYHPTTGVIETRLVTDPYSLSLSK
NSMYSQVIDLDDPSLMPQGWSDYERPTVKKDEDHVLYESHLRDFSFNDTK
GTKEYNGKYLALTEADRESVSHLQALKDAGLTTLHILPAFDIATVDEEAA
NRVDITDTVGKLCGIKPEASVCDEVDGAKVIEDVLNSYDPATGSAQALMN
DLRMLDSFNWGYDPFHYTVPEGSYATDPNGSKRILEFREMVQATHKMKLK
LIMDVVYNHTNASGINDKSVLDKIVPGYYHRLNVNTGGVENSTCCDNTAT
ENLMMGKLMVDSLKVWADDYKVDGFRFDLMGHQPKDVMVYALEQIRKIDE
NTLFYGEGWDFGEVSNNARFDQATQLNMAGTEIGTFSDRLRDAVRGGSPF
DGGVDSEGKHPLRFNQGFGNAAYANEETKVDAESVNGRLHNQDLVRLGMA
GNLADFVLLDYKGDTKLGKNVDYNGAPAGYTKVPSENISYVSKHDNQTLW
DNNAYKIATATPSADRARMQSVSLSTVMLGQGIPFIHMGSELLRSKSMQR
DSYDSGDWFNRVFFDGSDNNWNVGLPREDKDGANWELIKKIVSDTTAKPD
ATDIELTKQQFLELLKIRSSSELFRLDTAQEVMNRVDFRNVGKDQVEGLI
VMSIDDGKSAGADLDSKYDAIVAVVNSTSSEKSFVVKGATGFELHEVQQN
SADDIVKGASFANETFTVPALTTAVFVQPQDGAQGAGLPVNTDNKDVSSI
PPFGETVVYVKGTMNNWSDNSDWAMTFIGNGMYSVTGVLEAGSHEFKFAD
TGWANPNIGCSVATVGSGSLELGAEENCKLTVAETGKYNFTLNALYVQDE
KVEKPVVSVTKSADAPTFGETALYLRGTITSWDTPAQDSAAKFSYVANDV
YSLDIDLAAGSYEMKIASADWAADTNFGGEGSVELGKALTMEVGGGSANL
KIAIAEAGNYNFHFNAADKSAPIVTVTKN
>gid:502492  VPA1641  putative maltogenic amylase
MRNVLRNHRLYRSLLALSVIGALSACNSSGGDSNSSTPLPDTSYACQANV
MTQSNQLRTYQIMVESFVDGDTSIGHGTGYGTSHHNGDLQGVIDSLDYIQ
DLGMNAIWLTPVFESEAIAGQDHWADRLDATGYFATDYFKIDPKFGDLAT
AKTLVEEAHKRGLYVFFDGVFGHHKNGLIKPSPSGLLPSGSSNPVDYPAS
LDFYKEVATYWIKELKIDGWRLDQAYQVPTDAWTQLRKAVDEASQSVTYT
NSKGDQVNPLGYMVAEIWKGESEIANEAYGSNSDPALCSAFDFPMRYRIV
ETLAVNESGVGGRGVDWLDNGYSTHNQYPTHAQPNLMIGNHDLVRFGDLL
QRGNLADVNDAEYWLRHKAAFAFQAAYTGPITLYYGDEIGDQVDGFAAKE
DNNTCAIQGLCDDHVARSSAKIEGVTATLDANQADLKAYVTSLMTMRDTH
PALYQGSRTNLVASNGSYVDLKQSGSDKVLFALNTLESARTVILAQESVG
TGELVDLLTNEKIAPSNGQYQLPMSPLQGRFFAVTP
>gid:502495  VPA1644  maltose-inducible porin
MKKVSVIAAAVAATLAAGSAFAVDFHGYMRAGVGVNADGGQQLTFEKNKV
GRLGNESDIYGEIQLGKEVYNNNGKTFYVDSMLAMTSNGSNDWEGTAANC
GLDGTKVKCVDDAQFALRQFNVQAKGVLNFAPEATLWAGKRYYQRHDIHI
SDFYYWNISGAGAGVEGIEAGPGKLSFAWVRNDRNDNFNSGMGSGDTPDV
GNGGSVNVNTLDVRYAGIPVWENGSLEVGLDYALVNETEDASKAAKDAKD
GVMFTAELTQGLDSGFNKTVFQYGTEGYSKAFAFYGDGSWYGAEARDGAS
GYRFINWGVIGLGDNWELGHQLVYGVGEDMWAADHKWEAMSAVVRPVFKW
DDNHKTIFEAGYAIDDNDGDENKYGKLTVAQAWSAGSSFWARPEIRLYAS
YLTADKADNSNTFDSGRSDDTFQFGVQAEAWW
>gid:502496  VPA1645  glycogen operon protein GlgX
MTRLFSRPYPLGATLNKEGCNFSIHAPGVKDIQLALFASDGSYSLHDLPN
EYAGIRHTFIPDIKPGQKYGYVVTRRDEPLLISDPYAKSLDKALHYHPPY
TPAKSFDMPKCVVIEDTFDWQETDHPRIPREDMVLFETHVKGLTQLHPEV
SATTKGRYLGLASPQMLAFYKQQNINTLQLLPIAACMHEPHLLEMGKVNY
WGYNPYLFMVPDPRYAEKDAVTELKTTIRELHKHGIEVILDVVYNHTAEG
GEGATVFNLKALDSRFYIKHGNHFANYTGCGNTVDLTYQPALNLVMDTLR
YWVSEFKIDGFRFDLAATLGRQGDDYNPEAAFFKAVAQDPILRETKLIAE
PWDIGPNGYQVGNFPFGWNECNDKLRDISRSFWRGDQGYLKEFATRLMGS
RDIYSAANWPYKLTVNYITYHDGFTLQDLVSYKHKHNEANGEENRDGHGD
NRSENYGVEGETENIMIIATREKQKRNLIASLLFAFGIPHILTADVLSHS
QDGNNNAYCQDNKTSWINWSETERKAHFKTWMAQMVANRHQYMVPFIRAF
SGENRNNNRIFWRRTDGRLMEHDDWNRLSSVALHLGIGKDGQELVYLINQ
TNATARFKLPNERNQEWVTICDTNVRNLNPGHAEGEVLLSPTSMVILHYQ
PKPNSPQGEQLQS
>gid:502498  VPA1647  hypothetical multidrug resistance protein D
MNRPINFRTILLACLIISVGQLSMGLVMPSLPWIAKDFSVSLDQAQLLVS
IYLLGFGPSQFIYGPMSDALGRKKVLLAGLLIAMSGLLMIIFWSHTFTGM
VLGRFLQGLGTGCCAVLARASTRDQFSGNELPVAMSYIAMAASITPLIAP
VIGGFINFHFGWSMVFISLLGYVSLAWIIIAFRFKETITRRSAIPSPAKM
LVQYRDLLSSRYFMSFASISWLNFSLMITTVSVMPFIMQDQIGMTSDEYA
MWALIPALGMLGGTTICNRIRPVIGNKKMLLCTPVLHISAALWLFFCPVE
PLYLMIGQLLMILGNGIALPCAQALVMQPYKEQAGAAAAMSGGGQMVVSS
LVSMTLVQLGLSEAWHLSLVVVLFTAITLTNILRGFNTEEAQQHREVAEK
AS
>gid:502511  VPA1660  putative transport protein
MTKLIYSVLLCHFIAAFAALGMPLFLPVVLPTLGASIDADWAGVLFILPT
FCTALAARFWGNFADRYGRRRSLLRAQLGLAAGFALCGLADNLAMFVFGL
IVQGTFGGTMAASNSYLSSQIKEAKTLGKSLNKTQLSARLALIVAPIGLG
WSLSETNPLNAYLWLCVLPLIAMGITLTLPADTPAEQNLEKPNSESQQEQ
PVAKKNAMHAIRWIFFAQFGFAFSMVVTFPYFSPFVQQYGITNHAWIGFL
YALPHGVYLLLAGKIHVLSDGLNRHQPLRTLWLGFALLAVSSVLHLIASE
TALIAARIIFGIAMVCCYHGLHQHLASNLDRKLSGKVFSRFDAMSKWGGV
AAGFCASFISSLGLLEVPFLLSAIVSVITLISLVLHSKFGNQHVTNSILS
D
>gid:502514  VPA1663  putative binding protein component of ABC sugar transporter
MNKLAFLFPLLLAPGVAHAEPPQGVEFLHWWTSDGEQQALQTLKAQLKRH
DIELLQSPVLGGGGDSAMTVLQARALAGNPPSFAQIEGPSIKAWDAIGIL
HNVNAVADEQRWDEVLYPLSIEINKTQNGYIALPLTLHRLNWLWVNHKLL
KQLNLSAPKNWQEMFAAMELAEQNGIVPIAVGEQPWQVAQLFENLVISTG
GVEFYTNAMVKLERDSIDSETLRQALTQFRRLSLLIDNQLPDSKWDTATQ
ALADGQALFQIGGDWILGELLANQVSVPQEVGCYPTPDSDGVFLYNMDSL
VFMSSKSFSSEAAQQTASALADVEFQAKFNKVKGSIPVRTDIDISDFNPC
QVQSYQDFHYGVKHNLAVPSMIDSMAVNPVAQQAINSEIFRFYRNPKMEP
DELIKRIIAISQSG
>gid:502518  VPA1667  PTS system, glucose-specific IIBC component
MFASIFGQLQKIGRSLMLPVAVLPVAGLMLGIGNAGFGFIPDAVNKVMLA
AGEGVFGNMQLMFAVGVALGLSKGNDGAAALAGLVGLIIMNASLGIVTGL
RGLETDATIMGVETLQTGVFGGIFIGAVAAIMYNRFYNIKLPEYLGFFAG
KRFVPIVTGLSAIVVGAILAFAWPPVGQLLDAFSHWAAYQNPVLAWAVYG
VGERSLLPVGLHHIWNAPFFFEVGSYVDPETGKEFTGELTRFFAGDKTAG
YLSGGFMYSMWALPAAALAIYHCASPERKKIVGGLMMSAALTSWLTGITE
PIEFTFLFVAPVLYVIHIFLTGIAFAITAFLEIKHSTDFAHGAIQFFLYY
PMSSNAWMFIIIGPIWATLYYGLFRFLIVKLDLKTPGRETDIAEVKIAGQ
PDEIAVDVVAALGGKANIKSVDACITRLRVSVKDIANVDVAKLKALGARD
VLVIGDSLQAIFGTQSDSIKSEVHSVLAAS
>gid:502522  VPA1671  ABC-type arabinose transport system, permease component
MSVTSSTKILEQQDAKRSWNFAGIWDRFGMLMVFAGLFLLCAFFVPYFAT
FINMKGLGLAISMSGMVACAMLFCLACGDLDLSVASIIACSGVVTAVAIN
ATSSVVLGVGAGLLSGVAFGLLNGFVIAKLQINALITTLATMQIARGLGY
IISDGKAVGITEESFFALGNSSFIGIPTPIWLTIITFGVFAFLLNRTVYG
RNTLAIGGNEEAARLAGVNVVKTKMIIFTVSGFISALAGVILAARMTSGQ
PMTSVGFELVVISACVLGGVSLKGGIGKVSYVIAGVLILGTVENAMNLLN
MSPFAQYVVRGAILLAAVIFDRYKQTSRA
>gid:502523  VPA1672  L-arabinose transport ATP-binding protein
MIMINSPSYLEFCNISKHFPGVKALSNISFRANKGSIHALMGENGAGKST
LLKTLSGLHQPTEGELVVDGKALVFNSATDALEQGIAIIYQELNLVPELS
VAENIYLGQLPTKGGSVDVETLNARAREQLKRLGEDFDPSRPLKEFSIGQ
WQMVEIAKALSRNAQIIAFDEPTSSLSQREIQNLFKVIRELRDDGKIILY
VSHRMEEIFDLCDAITIFKDGTHVQTFDDMTDLTHEKLVELMVGREINDI
YNYRSRSLGESGLRIENLEGKGLTQPVSLDIRQGEILGLFGLVGAGRTEL
TRLIFGAEKAQAGQIYIHGQPISVRSPQDAIRAGITLCPEDRKADAIVPI
LSVEENTNISARPWNLKLGGLIDFKWERDNAEQQRKALNVKTASLQQAIG
QLSGGNQQKVILGRWLSTDMSVILLDEPTRGIDVGAKSEIYELIFNLAER
GVTVLVVSSDLPEVLGISDRVMVMKEGAVTGELQRHEFKEQTALSLAMLG
NNQAAA
>gid:502524  VPA1673  L-arabinose-binding periplasmic protein precursor
MKLKKLLTIAALSGMTMLSASANAFFGSNDDNVRLGYLVKQPEEPWFQTE
WSFAEKAAKQYDFELVKMAVPDGEKTLNAIDTLAASGAKGFVICTPDPKL
GPAIMAKAKSYDLKVITVDDQFLNAKGEPMKEVPLVMMAASEIGYRQGSE
LFKEMTNRGWDAATTGVMAITADELDTARRRVDGSVKALEDAGFPKSQIY
RVPTKTNDIPGALDAANSLLVQYPKVKQWLIVGMNDNTVLGGVRATEGQG
FAAENVIGIGINGVDAVNELAKSNATGFFGSLLPSPDVHGFKSIESLYKW
VKEDVQPEKFVEVTDVVLITRDNFREELQKKGL
>gid:502526  VPA1675  sugar isomerase SgaE, AraD/FucA family
MSEQTVWNDANSLVERIKTLRHQVWQANMDLQRHNLVTFTWGNVSGIDRE
SGLVVIKPSGVEYCELNAENMVVVDLHGQVVEGKLNPSSDTATHLELYRH
FPEIGGIVHTHSPQATAWAQAGRAIPALGTTHADYFYGQIACTRALSDEE
IAHNYELNTGKVIVETIGDSNVMASPGILVKEHAPFTWGKSPAQAVHNAV
VVEVVAGMALQTLQINAEVDTLNPSLLDKHYLRKHGANAYYGQSKK
>gid:502527  VPA1676  putative L-arabinose isomerase
MMKIFNDKQVWFVTGSQHLYGPQVLESVAQNSEEIIAGLNSSDDISVSIA
NKGTVKTPDEILAVCRAANNDPDCIGLMLWMHTFSPAKMWIAGLTQLNKP
FLHLHTQFNAALPWDEIDMDFMNLNQSAHGCREFGFIGTRLNIERKVVVG
HWQEPQVHRDIDDWCRAAIGVNAGQHLKVARFGDNMRQVAVTEGNKVSAQ
IQFGYEVNAYGLGELSDVVNSISDADVNHQLDKYACMYEMSPDLFNDSDL
KKLMAQEARLELGMESFLKSVGAGAFTNTFENLTGLTNLPGLATQRLMAK
GFGYGGEGDWKTAAMTHIMKVMGQGKPGGTSFMEDYTYNFGEKGQVLGAH
MLEVCPTIAAAKPRLEVHRHTIGCRCDIPRLIFSGQSGEALNVSIIDLGD
RFRMIVNVIDTVTPPQSLPHLPVAHALWEPQPNLNIAAAAWIHAGGAHHA
VYSQAVTLPMLADYAEILGIEMVVIDNSTNLRQFKQELRNNGVYYRLG
>gid:502542  VPA1691  hypothetical protein
MSNTTAKKSNPLFEILFNVFIPSFILMKYSGEEHLGTAMALVVALLFPVV
YGGMDLIRNKKFNFISALGFISVLLTGGIGLLELDTRWLALKEALIPGLI
GIAVLGSTFTRYPLMQKMVLNDTVLNLALINERLRENGKTDAFERCLMSS
NYLFASTFAFSSAMNYFLATWIVTSPSGTAAFNEELGKLTLYSYPMIAIP
SMLMMFGIFYYIWRQIRAMTSLETEQIFHIK
>gid:502546  VPA1695  6-phospho-beta-glucosidase
MKKNLKITIIGAGSSYTPELIEGLIKRNHELPIGELWLVDIEDGKEKVSI
IGDLTRRMLAKNNLSHIDVHVTLDRKPALKDADFVCSQFRAGCLEGRIRD
ERISLKYGMIGQETNGLGGFANACRTIPIALEICKEMEELCPDAWLLNFT
NPSGMVTEAILKHTKVKAVGLCNVPVIMQKGIAQMLGADEQDFVLQVAGL
NHFIWARQILHEGRDKLQDVVEAILSGNDPLVPQNIPPFEWPTELLRNMG
MIPCAYLRYYYTSEDIMKQEIEEANGEGTRGEVVKAMEKRLFDIYRNPEL
NEKPKELEKRGGQYYSEAACELMSSIYNDKRTIMHVNTRNNGAIAGLPDD
CTVEVSCMITKSGPVALNVAPFPTDTLRLIQLMKDFESLTVEAAVTGNRN
TAHRALILNPLVTTGTILEQALEETIQANLDYMPQFR
>gid:502551  VPA1700  mannonate dehydratase
MEQTWRWYGPNDPVSLDDIRQAGATGIVNALHHIPNGEVWSKEEILKRKA
IIEEKGLTWSVVESVPVHEEIKTLTGNFQQWIDNYKQTLRNLAECGVDTV
CYNFMPVLDWTRTDLEFEMPDGSKALRFDQIAFAAFELHILKRPGAEADY
TEAEQAQALEYFNNMTADQIQQLTSNIIAGLPGAEEGYTLEEFQAQLDRY
AGISKDKLREHMAYFLSQLMPVCEAHGLKLAVHPDDPPRPILGLPRIVST
IEDIDWLTEKVPSKMNGLTMCTGSYGVRGDNDLVKMIKKHGERIYFTHLR
STKREESNPMTFHEAAHLDGDVDMYNVVMAILDEEQRRAEVGDHRLIPMR
PDHGHQMLDDLKKKTNPGYSAIGRLKGLAEVRGLEMALKRAFYTK
>gid:502553  VPA1702  putative dicarboxylate-binding periplasmic protein
MMTRKTLLSAVVGAAMTFGATASAYAATTLKLSHNHPRDHAVHKAMDFMA
KEVREMTDGEVRIRIYPDAQLGTQRESMELMQNGALDMVKSNAAELEAFS
PAYAAFNMPYLFRDKDHYYKVTDGEVGREILNSSADSGFIGVTYYDAGAR
SFYTNKPINTPEDLKGLKVRVQPSPSAIAMVKALGGNPTPLAYGELYTAL
QQGVVDAAENNIPSFSLSRHSEVSKYFSLDEHTMVPDVLVISTKTYDKLT
PEQQKALMKAAADSSEYMKKLWAESEAKERTKAEKMGVTFVEPNKAAFVE
AVQPMYADLEKTNPELNELVEKIKAVK
>gid:502554  VPA1703  putative small integral C4-dicarboxylate membrane transport protein
MKMNKLVTYINRGLAAFTVSLSTFLVFCVVWQVLSRYVLGKPSTVTDELA
RYLFMWVALIGAAYTTGLKRHLAIDLLTMKLKGKKKLVNEIVIQVAIALF
SYVVLVHGGTQLALKTLATGQLTPALGLEMGYIYFCLPISGALMIFYSVI
FAYERVKQLMSGETLVTDSQLDS
>gid:502555  VPA1704  putative integral membrane protein, possible transporter
MEWQLILTLFGSFAVLLAIGVPVSFAIGLSSLATILMGLPLEPAIAVVAQ
RMAAGLDNFALLAIPFFILAGNIMNQGGIALRLINFAKVLGGRLPGSLAH
VNVMANMMFGSISGSAVASAAAVGGTMSPLQKKDGYDENFSAAVNITSCP
SGLLIPPSNTLIVFSLVSGGTSIAALFLAGYIPGILMGLSIMVVAGIIAK
RRGYPIAARPTLAMVWDTFLKAAPSLALIVVIMGGIIGGIFTATEASAIA
VVYTFVLAVLVYREVKWRDLPKIILESAVTTSIVLLLVGASMGMSWAMAN
ADIPYMIADALLAISDNPMMILLIINIILLIVGIFMDMTPAVLIFTPIFL
PIALDMGIDPVHFGIMMTFNLAIGICTPPVGSALFIGCSVANVAIDKVIK
PLLPFYVALIAALMAVTFIPELSLFLPKLVLGY
>gid:502556  VPA1705  mannonate oxidoreductase
MKTIANSTLNAAVSLPDYDRSTLKSRIIHLGFGAFHRAHQALFTHEMLSK
TSSDWGICEINLFGGEELIQSLRAQDHLYTVAEKGAQSTEVKVIGSVTES
LHPHLDSIQAVLEKMAEPQVAIVSMTITEKGYCADPATGTLDKNNPLVIA
DLANPTEPKSALGYIVQALKMRRERGLTPFTVMSCDNVQENGHVAKAAVL
EFAQLLDPELRDWIETNVTFPCTMVDRIVPAATEETLSEIAELVGCEDPC
GIACEPFRQWVIEDKFVAGRPDWNVAGAEFVADVVPYEEMKLRMLNGSHS
FLAYLGYLGGYAHISDTMTDEGYRKAAFDMMMQAQAPSLTMPEGTDLEGY
AKLLIERFTNPSLKHKTWQIAMDGSQKIPQRMGGSLRFHLAQGSNFSWLA
TAIAGWMRYVSGVDEQGNDIDVRDPMAETLRQICDQHGLNVSVVPALLAV
ETIFPAELGQNPQVIDAVSSAYQSLIDNGARATVAALK
>gid:502557  VPA1706  putative uronate isomerase
MKNFLCEDFLLSNETARRLYHEHAFHQPIYDYHCHLNPAEVTQNRQFDNL
GQIWLEGDHYKWRGMRSAGIEERLITGDASDYDKYMAWAKTVPQTLGNPL
YHWTHLELRRPFGITNTLFSPDTADQIWHQCNELLATPEFTARGIMQQMN
VVMAGTTDDPIDSLEHHKAIAEDDTFNVKVLPSWRPDKAFKIELDLFADY
MHKLGEVADIDIRRFDDLLSALDKRLAHFDSHGCRAADHGIEIVRYAPIP
SEADLDALLARRLSGEVLSELECAQFSTAVQVWLGKRYAQLGWVMQLHIG
AQRNNSTRMFQLLGADAGFDSIGDRPFAFELAHLLDEMDQTNELPRTILY
CLNPRDNEMMATMIGNFQGGGIAGKVQFGSGWWFNDQKDGMQRQMEQLSQ
LGLLSQFVGMLTDSRSFLSYTRHEYFRRILCDMVGRWAENGEVPNDLSLL
GPMVEDICFGNAKRYFEERA
>gid:502558  VPA1707  putative 2-dehydro-3-deoxygluconokinase
MKHIAIIGECMIELNGKPFGSMHQTFGGDTLNAAVYLSRGCEANSKPDKV
KVSYVTALGNDPISTGMLTRWEDEGISTDLVLRDEIRTPGLYLIQLDDQG
ERTFLYWRNQSAARYLLQHPNFGIVKQALTQVDAVFLSGISLAILPEEDR
ISLLNLLVELKAQGVEIAFDSNFRPALWPQDNNQTVKNVYQAMYQLTDVA
LVTFDDEQLIWGDETPEQTIERLTSLGVGKCIVKLGADGCLVQDPTNQGS
SAALAPQAVPTQPVAQVLDTTSAGDSFNGGFLSAYLAGADLATSCQRGNA
LAGAVIQHRGAIIPKAFTQPALGVV
>gid:502559  VPA1708  4-hydroxy-2-oxoglutarate aldolase/2-deydro-3-deoxyphosphogluconate aldolase
MSSIKEQLKALKVIPVIAIDKAEDIIPLGKVLAENGLPAAEITFRSAAAA
EAIRLLRETQPDMLIGAGTVLNREQAIAAKEAGATFIVSPGFNPNTVKAC
QEIGIDIVPGVNNPSTVEAALEMGLTTLKFFPAEASGGINMVKSLLAPYT
DIELMPTGGINPANIKDYLAIPRVLACGGTWMVDKKLIEEGNWEELARLT
REAVALVNE
>gid:502595  VPA1744  putative PTS system, sucrose-specific IIBC component
MAKITSNTVSQLLSAVGGSSNVSKCGNCMTRLRLSLANNGLADQSVIKKI
PGVMGVVESDEQFQIILGPGKAQQAAEMMNQLIDSLTSGDSEEPDMPQQD
LSAVAAEQKKQMKSKQTSAVQRFLSKFATIFTPLIPGFIAAGLLLGFATL
LEQMFVLDQTPSQFMLDLIAYMKVFGKGLFAFLSILIGYNAQQAFGGSGV
NGAILASLFVLGYNPEATSGIYSGMNEFFGFAIDPRGNIIGVLLAAIIGA
QVERKVRQYMPDDLDMILTSVITLLIMGAVTFLIIMPIGGELFKGMSWLF
LNLNDNPLGAAILAGLFLISVVFGIHQGFVPVYFALMEAQGFNSLFPILA
MAGGGQVGASMALYFKAKKDALLRTQVKGAIIPGLLGIGEPLIYGVTLPR
VKPFVTACIGGAAGGFFIGLVSYLGLPVGLNTVFGPSGIVAIPLMTSENG
IFPGMMVFVAGLLISYIVGFLATYFFGCKDVDLS